| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH1 MYH2 MYH4 MYH7 MYO6 SMC1A SRPRA ABCA10 DDX6 DDX10 CLPB DDX18 AFG3L2 SHPRH HYOU1 UBA2 CHD8 CHD7 MORC4 FIGN NUBPL HELQ DNAH1 ABCG1 ABCE1 DNAH17 ENTPD2 KIF4B SMC1B DNAH11 | 1.27e-12 | 614 | 205 | 30 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 MYH7 SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 RAB27A RAB27B EEFSEC REM1 CHD8 CHD7 MORC4 FIGN HELQ SAR1A ABCG1 ABCE1 SAR1B ENTPD2 SMC1B DNAH11 | 1.71e-09 | 775 | 205 | 29 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 MYH7 SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 RAB27A RAB27B EEFSEC REM1 CHD8 CHD7 MORC4 FIGN HELQ SAR1A ABCG1 ABCE1 SAR1B ENTPD2 SMC1B DNAH11 | 1.01e-08 | 839 | 205 | 29 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 MYH7 SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 RAB27A RAB27B EEFSEC REM1 CHD8 CHD7 MORC4 FIGN HELQ SAR1A ABCG1 ABCE1 SAR1B ENTPD2 SMC1B DNAH11 | 1.04e-08 | 840 | 205 | 29 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 MYH7 SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 RAB27A RAB27B EEFSEC REM1 CHD8 CHD7 MORC4 FIGN HELQ SAR1A ABCG1 ABCE1 SAR1B ENTPD2 SMC1B DNAH11 | 1.04e-08 | 840 | 205 | 29 | GO:0016818 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 MYH7 SMC1A SRPRA ABCA10 DDX6 DDX10 CLPB DDX18 AFG3L2 CHD8 CHD7 MORC4 FIGN HELQ ABCG1 ABCE1 ENTPD2 SMC1B DNAH11 | 3.15e-08 | 441 | 205 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.62e-06 | 118 | 205 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | actin filament binding | MYH1 MYH2 MYH4 MYH7 MYO6 SPTBN5 PLEC FLNA FLNB FLNC EGFR SCIN | 4.20e-06 | 227 | 205 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | G protein activity | 3.12e-05 | 59 | 205 | 6 | GO:0003925 | |
| GeneOntologyMolecularFunction | actin binding | MYH1 MYH2 MYH4 MYH7 MYO6 GBP2 GBP3 SPTBN5 MYOZ1 PLEC FLNA FLNB FLNC DYRK1A EGFR SCIN | 3.75e-05 | 479 | 205 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | microfilament motor activity | 4.14e-05 | 38 | 205 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 6.45e-05 | 67 | 205 | 6 | GO:0031492 | |
| GeneOntologyMolecularFunction | nucleosome binding | 6.81e-05 | 98 | 205 | 7 | GO:0031491 | |
| GeneOntologyMolecularFunction | amino acid sensor activity | 1.05e-04 | 2 | 205 | 2 | GO:0140785 | |
| GeneOntologyMolecularFunction | GDP phosphatase activity | 2.19e-04 | 12 | 205 | 3 | GO:0004382 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 5.46e-04 | 37 | 205 | 4 | GO:0045505 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 5.82e-04 | 100 | 205 | 6 | GO:0030527 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.77e-04 | 18 | 205 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | GTPase activity | GBP2 GBP3 SRPRA GSPT2 RAB27A RAB27B EEFSEC REM1 SAR1A ABCE1 SAR1B | 8.31e-04 | 341 | 205 | 11 | GO:0003924 |
| GeneOntologyMolecularFunction | nucleoside diphosphate phosphatase activity | 1.07e-03 | 20 | 205 | 3 | GO:0017110 | |
| GeneOntologyMolecularFunction | helicase activity | 1.25e-03 | 158 | 205 | 7 | GO:0004386 | |
| GeneOntologyMolecularFunction | lipopolysaccharide binding | 1.47e-03 | 48 | 205 | 4 | GO:0001530 | |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 1.53e-03 | 6 | 205 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | chromatin binding | ASXL1 SMC1A H1-9P HP1BP3 TAF2 H1-10 KAT6A CHD8 CHD7 NR3C1 EGFR H1-0 H1-3 H1-5 ANKRD17 H1-1 CTNNB1 | 1.67e-03 | 739 | 205 | 17 | GO:0003682 |
| GeneOntologyBiologicalProcess | nucleosome organization | 1.47e-06 | 142 | 203 | 10 | GO:0034728 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 3.39e-06 | 122 | 203 | 9 | GO:0006334 | |
| GeneOntologyBiologicalProcess | chromosome condensation | 7.34e-06 | 48 | 203 | 6 | GO:0030261 | |
| GeneOntologyBiologicalProcess | chromosome organization | SMC1A H1-9P TTK SPICE1 H1-10 FLNA PDCD6IP KAT6A CHD8 HELQ RESF1 FSHR H1-0 H1-3 H1-5 SENP6 KIF4B H1-1 CTNNB1 SMC1B | 1.54e-05 | 686 | 203 | 20 | GO:0051276 |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 1.64e-05 | 55 | 203 | 6 | GO:0045910 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine modification | 3.35e-05 | 162 | 203 | 9 | GO:0018205 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H1-9P HP1BP3 SHPRH TAF2 H1-10 KAT6A H1-0 H1-3 H1-5 SENP6 H1-1 | 3.81e-05 | 249 | 203 | 11 | GO:0065004 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 7.55e-05 | 9 | 203 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 1.22e-04 | 150 | 203 | 8 | GO:0000018 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH1 MYH2 MYH4 MYH7 MYO6 GBP2 GBP3 SPTBN5 MYOZ1 FLNA FLNB FLNC PDCD6IP DYRK1A ACTR1B ACTR1A H1-0 CGNL1 SCIN | 4.01e-06 | 576 | 204 | 19 | GO:0015629 |
| GeneOntologyCellularComponent | sarcomere | MYH1 MYH2 MYH4 MYH7 MYOZ1 PLEC FLNA FLNB FLNC REM1 MYOM3 CTNNB1 | 6.49e-06 | 249 | 204 | 12 | GO:0030017 |
| GeneOntologyCellularComponent | nucleosome | 8.71e-06 | 138 | 204 | 9 | GO:0000786 | |
| GeneOntologyCellularComponent | muscle myosin complex | 1.46e-05 | 16 | 204 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH7 MYOZ1 PLEC FLNA FLNB FLNC REM1 MYOM3 CTNNB1 | 1.64e-05 | 273 | 204 | 12 | GO:0030016 |
| GeneOntologyCellularComponent | myosin complex | 2.35e-05 | 59 | 204 | 6 | GO:0016459 | |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH7 MYOZ1 PLEC FLNA FLNB FLNC REM1 MYOM3 CTNNB1 | 2.97e-05 | 290 | 204 | 12 | GO:0043292 |
| GeneOntologyCellularComponent | multi-pass translocon complex | 7.37e-05 | 9 | 204 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | myosin filament | 9.49e-05 | 25 | 204 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.50e-04 | 28 | 204 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | I band | 2.32e-04 | 166 | 204 | 8 | GO:0031674 | |
| GeneOntologyCellularComponent | myelin sheath | 2.92e-04 | 217 | 204 | 9 | GO:0043209 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 3.08e-04 | 14 | 204 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 4.71e-04 | 101 | 204 | 6 | GO:0045334 | |
| GeneOntologyCellularComponent | internode region of axon | 5.61e-04 | 4 | 204 | 2 | GO:0033269 | |
| GeneOntologyCellularComponent | euchromatin | 6.94e-04 | 72 | 204 | 5 | GO:0000791 | |
| GeneOntologyCellularComponent | Z disc | 7.18e-04 | 151 | 204 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 7.37e-04 | 42 | 204 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | coated vesicle | MYO6 TYRP1 RAB27A RAB27B SFTPD APOB SYT2 SAR1A ACTR1A EGFR SAR1B | 8.58e-04 | 360 | 204 | 11 | GO:0030135 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.05e-03 | 161 | 204 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | host intracellular region | 1.39e-03 | 6 | 204 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 1.39e-03 | 6 | 204 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 1.39e-03 | 6 | 204 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 1.39e-03 | 6 | 204 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 1.39e-03 | 6 | 204 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 1.39e-03 | 6 | 204 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 1.39e-03 | 6 | 204 | 2 | GO:0020005 | |
| GeneOntologyCellularComponent | anchoring junction | MYH1 MYH2 NCAM1 DDX6 TJP2 PLEC SDCBP FLNA FLNB FLNC HYOU1 PDCD6IP PDPK2P EGFR CGNL1 CTNNB1 PATJ PARD3 SCIN RPL5 | 1.44e-03 | 976 | 204 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | mitochondrial nucleoid | 1.54e-03 | 51 | 204 | 4 | GO:0042645 | |
| GeneOntologyCellularComponent | nucleoid | 1.54e-03 | 51 | 204 | 4 | GO:0009295 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.83e-03 | 131 | 204 | 6 | GO:0005923 | |
| GeneOntologyCellularComponent | meiotic cohesin complex | 1.93e-03 | 7 | 204 | 2 | GO:0030893 | |
| GeneOntologyCellularComponent | mitochondrial matrix | MCCC2 SLC25A5 POLRMT NR3C1 CPS1 NUBPL CBR4 LIPT1 ABCE1 FLAD1 MRPS11 MRPL46 SOD2 | 1.96e-03 | 523 | 204 | 13 | GO:0005759 |
| GeneOntologyCellularComponent | clathrin-coated vesicle | 2.35e-03 | 237 | 204 | 8 | GO:0030136 | |
| GeneOntologyCellularComponent | tight junction | 2.46e-03 | 139 | 204 | 6 | GO:0070160 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.46e-03 | 139 | 204 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | dynactin complex | 2.55e-03 | 8 | 204 | 2 | GO:0005869 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.55e-03 | 8 | 204 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.55e-03 | 8 | 204 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | other organism part | 3.26e-03 | 9 | 204 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | brush border | 3.83e-03 | 152 | 204 | 6 | GO:0005903 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 3.95e-03 | 153 | 204 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.05e-03 | 10 | 204 | 2 | GO:0044614 | |
| HumanPheno | Sudden episodic apnea | 9.31e-06 | 19 | 82 | 5 | HP:0002882 | |
| HumanPheno | Fibular aplasia | 1.89e-05 | 11 | 82 | 4 | HP:0002990 | |
| MousePheno | conjunctivitis | 1.23e-05 | 26 | 167 | 5 | MP:0001852 | |
| Domain | Histone_H1/H5_H15 | 3.09e-15 | 14 | 201 | 9 | IPR005818 | |
| Domain | H15 | 1.92e-13 | 13 | 201 | 8 | SM00526 | |
| Domain | Linker_histone | 1.92e-13 | 13 | 201 | 8 | PF00538 | |
| Domain | H15 | 1.92e-13 | 13 | 201 | 8 | PS51504 | |
| Domain | P-loop_NTPase | MYH1 MYH2 MYH4 MYH7 MYO6 SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 SHPRH TJP2 RAB27A RAB27B EEFSEC NWD1 REM1 CHD8 CHD7 FIGN NUBPL HELQ SAR1A DNAH1 ABCG1 ABCE1 SAR1B KIF4B DSEL SMC1B DNAH11 | 2.75e-13 | 848 | 201 | 37 | IPR027417 |
| Domain | - | SMC1A GBP2 GBP3 SRPRA ABCA10 DDX6 DDX10 GSPT2 CLPB DDX18 AFG3L2 SHPRH TJP2 RAB27A RAB27B EEFSEC NWD1 REM1 CHD8 CHD7 FIGN NUBPL HELQ SAR1A DNAH1 ABCG1 ABCE1 SAR1B DSEL SMC1B DNAH11 | 1.02e-10 | 746 | 201 | 31 | 3.40.50.300 |
| Domain | Histone_H5 | 7.49e-09 | 8 | 201 | 5 | IPR005819 | |
| Domain | Myosin_tail_1 | 1.05e-06 | 18 | 201 | 5 | PF01576 | |
| Domain | Myosin_tail | 1.05e-06 | 18 | 201 | 5 | IPR002928 | |
| Domain | ACTININ_2 | 3.95e-06 | 23 | 201 | 5 | PS00020 | |
| Domain | ACTININ_1 | 3.95e-06 | 23 | 201 | 5 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.95e-06 | 23 | 201 | 5 | IPR001589 | |
| Domain | DUF2012 | 4.87e-06 | 4 | 201 | 3 | PF09430 | |
| Domain | DUF2012 | 4.87e-06 | 4 | 201 | 3 | IPR019008 | |
| Domain | Myosin_N | 1.62e-05 | 15 | 201 | 4 | PF02736 | |
| Domain | Myosin_N | 1.62e-05 | 15 | 201 | 4 | IPR004009 | |
| Domain | CarboxyPept-like_regulatory | 2.78e-05 | 17 | 201 | 4 | IPR008969 | |
| Domain | Myosin-like_IQ_dom | 4.45e-05 | 19 | 201 | 4 | IPR027401 | |
| Domain | - | 4.45e-05 | 19 | 201 | 4 | 4.10.270.10 | |
| Domain | Myosin_head_motor_dom | 5.17e-05 | 38 | 201 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.17e-05 | 38 | 201 | 5 | PS51456 | |
| Domain | Myosin_head | 5.17e-05 | 38 | 201 | 5 | PF00063 | |
| Domain | MYSc | 5.17e-05 | 38 | 201 | 5 | SM00242 | |
| Domain | WHTH_DNA-bd_dom | H1-9P HP1BP3 SHPRH H1-10 KAT6A RFX6 HELQ H1-0 H1-3 H1-5 H1-1 | 6.52e-05 | 242 | 201 | 11 | IPR011991 |
| Domain | Carb-bd-like_fold | 6.61e-05 | 8 | 201 | 3 | IPR013784 | |
| Domain | SAR1 | 1.15e-04 | 2 | 201 | 2 | PS51422 | |
| Domain | Arp1 | 1.15e-04 | 2 | 201 | 2 | IPR029909 | |
| Domain | Small_GTPase_SAR1 | 1.15e-04 | 2 | 201 | 2 | IPR006687 | |
| Domain | IG_FLMN | 1.39e-04 | 10 | 201 | 3 | SM00557 | |
| Domain | Helicase_C | 1.58e-04 | 107 | 201 | 7 | PF00271 | |
| Domain | HELICc | 1.58e-04 | 107 | 201 | 7 | SM00490 | |
| Domain | Helicase_C | 1.68e-04 | 108 | 201 | 7 | IPR001650 | |
| Domain | AAA | 1.69e-04 | 144 | 201 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 1.69e-04 | 144 | 201 | 8 | IPR003593 | |
| Domain | HELICASE_CTER | 1.78e-04 | 109 | 201 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.78e-04 | 109 | 201 | 7 | PS51192 | |
| Domain | DEXDc | 1.78e-04 | 109 | 201 | 7 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.88e-04 | 110 | 201 | 7 | IPR014001 | |
| Domain | Filamin | 1.90e-04 | 11 | 201 | 3 | PF00630 | |
| Domain | FILAMIN_REPEAT | 1.90e-04 | 11 | 201 | 3 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 1.90e-04 | 11 | 201 | 3 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 1.90e-04 | 11 | 201 | 3 | IPR017868 | |
| Domain | CarboxyPept_regulatory_dom | 3.24e-04 | 13 | 201 | 3 | IPR014766 | |
| Domain | - | 3.24e-04 | 13 | 201 | 3 | 2.60.40.1120 | |
| Domain | - | 6.08e-04 | 218 | 201 | 9 | 1.10.10.10 | |
| Domain | CH | 6.72e-04 | 65 | 201 | 5 | SM00033 | |
| Domain | Neural_cell_adh | 6.82e-04 | 4 | 201 | 2 | IPR009138 | |
| Domain | DUF4217 | 6.82e-04 | 4 | 201 | 2 | PF13959 | |
| Domain | DUF4217 | 6.82e-04 | 4 | 201 | 2 | SM01178 | |
| Domain | DUF4217 | 6.82e-04 | 4 | 201 | 2 | IPR025313 | |
| Domain | CH | 9.43e-04 | 70 | 201 | 5 | PF00307 | |
| Domain | - | 1.01e-03 | 71 | 201 | 5 | 1.10.418.10 | |
| Domain | SMC | 1.13e-03 | 5 | 201 | 2 | IPR024704 | |
| Domain | CH | 1.14e-03 | 73 | 201 | 5 | PS50021 | |
| Domain | CH-domain | 1.29e-03 | 75 | 201 | 5 | IPR001715 | |
| Domain | BRK | 1.68e-03 | 6 | 201 | 2 | SM00592 | |
| Domain | SMC_hinge | 1.68e-03 | 6 | 201 | 2 | SM00968 | |
| Domain | BRK_domain | 1.68e-03 | 6 | 201 | 2 | IPR006576 | |
| Domain | SMC_hinge | 1.68e-03 | 6 | 201 | 2 | PF06470 | |
| Domain | SMC_hinge | 1.68e-03 | 6 | 201 | 2 | IPR010935 | |
| Domain | BRK | 1.68e-03 | 6 | 201 | 2 | PF07533 | |
| Domain | IQ | 1.82e-03 | 81 | 201 | 5 | SM00015 | |
| Domain | ABC_transporter-like | 2.04e-03 | 50 | 201 | 4 | IPR003439 | |
| Domain | zf-CW | 2.34e-03 | 7 | 201 | 2 | PF07496 | |
| Domain | ZF_CW | 2.34e-03 | 7 | 201 | 2 | PS51050 | |
| Domain | Znf_CW | 2.34e-03 | 7 | 201 | 2 | IPR011124 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.78e-06 | 52 | 159 | 7 | M2341 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 1.03e-05 | 13 | 159 | 4 | M1018 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.13e-05 | 27 | 159 | 5 | M47755 | |
| Pathway | REACTOME_APOPTOTIC_EXECUTION_PHASE | 1.75e-05 | 49 | 159 | 6 | MM15448 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 3.28e-05 | 142 | 159 | 9 | MM15178 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 3.31e-05 | 17 | 159 | 4 | M27189 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 1.17e-04 | 43 | 159 | 5 | M47669 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.24e-04 | 132 | 159 | 8 | M11355 | |
| Pathway | REACTOME_PROGRAMMED_CELL_DEATH | 1.40e-04 | 211 | 159 | 10 | M27436 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.45e-04 | 45 | 159 | 5 | M47670 | |
| Pathway | WP_NPHP1_DELETION_SYNDROME | 2.17e-04 | 11 | 159 | 3 | M48099 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 2.87e-04 | 12 | 159 | 3 | MM14554 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SMC1A RPS6KA3 SRP72 SRPRA MCCC2 PTBP1 TTK DDX6 HP1BP3 DDX10 SLC25A3 DDX18 AFG3L2 MIB1 TJP2 CRYBG1 PLEC FAR1 H1-10 FLNA HYOU1 PDCD6IP SLC25A5 UBA2 CHD8 CHD7 DIS3 ORC2 ABCE1 SLC25A1 GYS1 H1-0 H1-3 H1-5 MRPS11 AGRN RPL5 | 4.99e-15 | 1318 | 209 | 37 | 30463901 |
| Pubmed | MLEC MYO6 SMC1A SPART SRP72 SRPRA TTK DDX6 SPICE1 SLC25A3 PTPN13 AFG3L2 FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 GNB1L NPLOC4 EGFR ABCE1 ARFGAP1 ANKRD17 CRYBG3 PATJ PARD3 RPL5 | 2.87e-14 | 708 | 209 | 27 | 39231216 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO6 SMC1A MCCC2 PTBP1 ARMCX1 DDX6 DDX10 SLC25A3 DDX18 AFG3L2 MIB1 TAF2 PLEC FAR1 H1-10 FLNA FLNB FLNC RANGAP1 PDCD6IP SLC25A5 POLRMT CHD8 CHD7 DIS3 ACTR1B ACTR1A ABCE1 SLC25A1 H1-0 H1-5 ANKRD17 H1-1 PARD3 AGRN RPL5 | 6.10e-14 | 1353 | 209 | 36 | 29467282 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MLEC GBP3 MCCC2 PTBP1 DDX6 HP1BP3 MOGS DDX18 PLEC H1-10 FLNA FLNB FLNC HYOU1 PDCD6IP SLC25A5 MUC19 CHD8 SAR1A DNAH1 ACTR1A ABCE1 SLC25A1 SAR1B H1-0 H1-3 H1-5 RPL5 | 9.38e-14 | 807 | 209 | 28 | 30575818 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | MYH2 MYH7 MYO6 PTBP1 DDX6 SLC25A3 DDX18 RGPD3 TJP2 PLEC FLNA FLNB PDCD6IP SLC25A5 POLRMT CHD7 SAR1A C4orf54 ACTR1A SAR1B H1-0 H1-5 KIF4B CTNNB1 RPL5 | 9.95e-14 | 626 | 209 | 25 | 33644029 |
| Pubmed | MLEC MYO6 SPART SRPRA MCCC2 TTK HP1BP3 SPICE1 DDX10 ZNF512B PASK PTPN13 MOGS CLPB NOMO2 DDX18 AFG3L2 MIB1 CCSER2 FAR1 H1-10 RANGAP1 HYOU1 GNB1L POLRMT NR3C1 NOMO1 WDR19 EGFR PANK4 MRPS11 CRYBG3 CTNNB1 MRPL46 PARD3 RPL5 HERC5 | 1.98e-13 | 1487 | 209 | 37 | 33957083 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYO6 SMC1A SRP72 SRPRA PTBP1 DDX6 HP1BP3 SLC25A3 MOGS DDX18 AFG3L2 TJP2 CRYBG1 PLEC H1-10 FLNA ELOA FLNB HYOU1 PDCD6IP SLC25A5 POLRMT EDIL3 NOSIP ACTR1A EGFR SLC25A1 H1-0 H1-3 H1-5 ANKRD17 CTNNB1 PATJ RPL5 | 2.10e-13 | 1257 | 209 | 34 | 36526897 |
| Pubmed | SRP72 HP1BP3 DDX10 DDX18 TJP2 PLEC H1-10 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP POLRMT CHD8 CHD7 DIS3 ABCE1 H1-3 ANKRD17 H1-1 RPL5 HERC5 | 1.31e-11 | 653 | 209 | 23 | 22586326 | |
| Pubmed | MYO6 SMC1A SPART PTBP1 DDX6 SLC25A3 AFG3L2 FAR1 FLNA FLNB HYOU1 PDCD6IP CHD8 DIS3 ACTR1A ABCE1 SLC25A1 ANKRD17 CTNNB1 RPL5 NOMO3 | 1.40e-11 | 534 | 209 | 21 | 35032548 | |
| Pubmed | Role of H1 linker histones in mammalian development and stem cell differentiation. | 1.97e-11 | 11 | 209 | 6 | 26689747 | |
| Pubmed | IMPDH1 MYO6 SMC1A SRP72 MCCC2 PTBP1 DDX6 SPICE1 SLC25A3 KANK1 GSPT2 DDX18 AFG3L2 H1-10 FLNA RANGAP1 PDCD6IP SLC25A5 DIS3 DNAH1 ACTR1A ABCE1 WDR87 SLC25A1 H1-0 H1-3 ANKRD17 CTNNB1 PATJ PARD3 RPL5 | 2.30e-11 | 1247 | 209 | 31 | 27684187 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MLEC MYO6 SMC1A SPART SRPRA MCCC2 PTBP1 PGM3 DDX6 SLC25A3 CLPB NOMO2 RGPD3 AFG3L2 FAR1 H1-10 RANGAP1 SLC25A5 MORC4 DIS3 NPLOC4 NOMO1 ACTR1A ABCE1 SLC25A1 PANK4 H1-3 H1-1 CTNNB1 RPL5 NOMO3 | 2.81e-11 | 1257 | 209 | 31 | 37317656 |
| Pubmed | A unified phylogeny-based nomenclature for histone variants. | 3.93e-11 | 12 | 209 | 6 | 22650316 | |
| Pubmed | MYH1 MYH2 MYH4 MLEC SRP72 PTBP1 DDX6 SLC25A3 MOGS CLPB RGPD3 UGP2 PLEC FLNA FLNB FLNC SLC25A5 NPLOC4 NOSIP ABCE1 SLC25A1 H1-3 H1-1 CTNNB1 RPL5 | 6.42e-11 | 844 | 209 | 25 | 25963833 | |
| Pubmed | SMC1A SPART MCCC2 PTBP1 PGM3 DDX6 HP1BP3 SLC25A3 MOGS DDX18 AFG3L2 FAR1 H1-10 FLNA FLNC HYOU1 SLC25A5 CPS1 NUBPL DIS3 SLC25A1 H1-0 RPL5 | 1.04e-10 | 725 | 209 | 23 | 27025967 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SMC1A SRP72 SRPRA MCCC2 PTBP1 DDX6 HP1BP3 SLC25A3 GSPT2 MOGS DDX18 AFG3L2 PLEC SDCBP H1-10 FLNA FLNB RANGAP1 HYOU1 PDCD6IP LEO1 SLC25A5 GNB1L CPS1 DIS3 NPLOC4 NOSIP EGFR SLC25A1 H1-5 MRPL46 RPL5 | 1.18e-10 | 1415 | 209 | 32 | 28515276 |
| Pubmed | MYH2 MLEC RPS6KA3 SRP72 SRPRA PTBP1 PGM3 DDX6 SLC25A3 CLPB AFG3L2 TJP2 FAR1 RAB27A FLNA FLNB RANGAP1 HYOU1 PDCD6IP POLRMT NUBPL DIS3 NPLOC4 ACTR1A LIPT1 ARFGAP1 PANK4 H1-0 H1-5 MRPS11 CTNNB1 HERC5 | 1.83e-10 | 1440 | 209 | 32 | 30833792 | |
| Pubmed | MYH1 MYH2 MYH4 MYH7 SRP72 PTBP1 HP1BP3 GSPT2 RGPD3 UGP2 PLEC METTL25 PLXNA2 FLNA ELOA FLNB FLNC RANGAP1 HYOU1 LEO1 SLC25A5 PCDHGA11 APOB SLC25A1 ENTPD2 H1-0 H1-3 H1-5 CFAP74 H1-1 USPL1 PCDHGA8 | 1.89e-10 | 1442 | 209 | 32 | 35575683 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MLEC SMC1A RPS6KA3 SRPRA PGM3 PASK CLPB AFG3L2 TJP2 FAR1 FLNA FLNB FLNC HYOU1 PDCD6IP LEO1 POLRMT UBA2 DIS3 NPLOC4 NOMO1 ABCE1 FLAD1 H1-5 ANKRD17 RPL5 | 2.44e-10 | 974 | 209 | 26 | 28675297 |
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | SRP72 MCCC2 PTBP1 PGM3 SLC25A3 MOGS FAR1 H1-10 FLNA RANGAP1 PDCD6IP SLC25A5 SLC25A1 H1-0 H1-5 H1-1 | 3.72e-10 | 344 | 209 | 16 | 36282215 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SMC1A SRP72 PTBP1 DDX6 HP1BP3 ZNF512B SLC25A3 PTPN13 MOGS DDX18 MIOS PLEC ELOA FLNC RANGAP1 PDCD6IP SLC25A5 CHD7 EDIL3 SETD2 ZNF532 SLC25A1 GYS1 MRPS11 MRPL46 AGRN RPL5 | 4.68e-10 | 1082 | 209 | 27 | 38697112 |
| Pubmed | SRP72 SRPRA HP1BP3 MOGS AFG3L2 EEFSEC HYOU1 LEO1 POLRMT CHD8 NR3C1 DIS3 NPLOC4 ABCE1 DDHD1 H1-3 ANKRD17 CRYBG3 PATJ AGRN RPL5 | 5.09e-10 | 650 | 209 | 21 | 38777146 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MYO6 SPART HP1BP3 DDX10 ZNF512B SLC25A3 PTPN13 AFG3L2 SDCBP FLNA ELOA RANGAP1 NR3C1 DIS3 NPLOC4 ORC2 SETD2 ABCE1 ARFGAP1 SENP6 ANKRD17 CGNL1 SCIN RPL5 HERC5 | 5.25e-10 | 934 | 209 | 25 | 33916271 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | SPART MCCC2 TTK NOMO2 AFG3L2 LEO1 UBA2 CHD7 NR3C1 MORC4 DIS3 NOSIP SETD2 RESF1 SENP6 CGNL1 CRYBG3 CTNNB1 PATJ SCIN | 5.56e-10 | 588 | 209 | 20 | 38580884 |
| Pubmed | MYO6 SRP72 MCCC2 PTBP1 TTK DDX6 HP1BP3 SLC25A3 PASK MOGS CLPB AFG3L2 H1-10 RANGAP1 HYOU1 SLC25A5 POLRMT NPLOC4 NOSIP ORC2 ACTR1A RESF1 WDR87 FLAD1 GYS1 H1-0 MRPS11 H1-1 MRPL46 RPL5 | 5.57e-10 | 1335 | 209 | 30 | 29229926 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MLEC MYO6 SMC1A SRP72 MCCC2 PTBP1 DDX6 DDX10 SLC25A3 MOGS CLPB DDX18 FAR1 SDCBP H1-10 FLNA FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 GNB1L POLRMT APOB SAR1A DIS3 NOMO1 ACTR1A ABCE1 H1-0 RPL5 | 6.08e-10 | 1425 | 209 | 31 | 30948266 |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | MORC1 MLEC MYO6 PTBP1 SLC25A3 TJP2 PLEC SDCBP H1-10 FLNA FLNB FLNC HYOU1 SLC25A5 SLC25A1 H1-0 H1-3 RPL5 | 6.10e-10 | 468 | 209 | 18 | 36042349 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | SMC1A PTBP1 DDX6 HP1BP3 DDX10 ZNF512B SLC25A3 DDX18 AFG3L2 TJP2 PLEC FAR1 H1-10 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP SLC25A5 EDIL3 SAR1A H1-0 CTNNB1 SCIN RPL5 | 7.03e-10 | 1024 | 209 | 26 | 24711643 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | MYO6 SMC1A SRP72 PTBP1 HP1BP3 DDX10 SLC25A3 GSPT2 DDX18 TAF2 PLEC H1-10 FLNA FLNB RANGAP1 SLC25A5 APOB CPS1 ACTR1A SLC25A1 H1-0 H1-3 H1-5 RPL5 HERC5 | 7.27e-10 | 949 | 209 | 25 | 36574265 |
| Pubmed | Dynamic changes in H1 subtype composition during epigenetic reprogramming. | 1.84e-09 | 10 | 209 | 5 | 28794128 | |
| Pubmed | SRP72 SRPRA PTBP1 DDX6 SLC25A3 MOGS DDX18 TJP2 PLEC EEFSEC H1-10 FLNA FLNB HYOU1 SLC25A5 ACTR1A ABCE1 ARFGAP1 CTNNB1 MRPL46 RPL5 | 2.50e-09 | 711 | 209 | 21 | 33022573 | |
| Pubmed | MYO6 MBP SRP72 NCAM1 NCAM2 PTBP1 DDX6 HP1BP3 SLC25A3 AFG3L2 UGP2 MIOS TJP2 PLEC SDCBP FLNA FLNB FLNC HYOU1 PDCD6IP SLC25A5 DYRK1A ACTR1A TENM4 H1-0 H1-3 CGNL1 CTNNB1 RPL5 DNAH11 | 2.79e-09 | 1431 | 209 | 30 | 37142655 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 3.35e-09 | 11 | 209 | 5 | 16024798 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | CMTR1 MYO6 SPART SRPRA TTK DDX6 DDX10 PTPN13 DDX18 TJP2 TAF2 PLEC EEFSEC FLNA FLNC RANGAP1 HYOU1 NOSIP H1-5 ANKRD17 RPL5 | 3.44e-09 | 724 | 209 | 21 | 36232890 |
| Pubmed | MLEC SPART ZNF512B PASK MIB1 CCSER2 MED12L RANGAP1 PDCD6IP CHD8 DIS3 NPLOC4 WDR19 LRIG3 ZNF532 DDHD1 SENP6 ANKRD17 | 4.18e-09 | 529 | 209 | 18 | 14621295 | |
| Pubmed | IMPDH1 MYO6 RPS6KA3 SRP72 SRPRA PTBP1 DDX6 HP1BP3 DDX10 SLC25A3 MOGS CLPB DDX18 TJP2 PLEC CA3 EEFSEC FLNA ELOA SLC25A5 APOB CHD7 NUBPL NPLOC4 NOSIP SLC25A1 ANKRD17 CTNNB1 PARD3 | 4.33e-09 | 1371 | 209 | 29 | 36244648 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | MLEC NCAM1 PTBP1 HP1BP3 SLC25A3 MOGS AFG3L2 CCSER2 TAF2 PLEC FAR1 RAB27A H1-10 FLNA ELOA FLNC RANGAP1 SLC25A5 DYRK1A CHD8 ORC2 ZNF532 H1-0 H1-1 CTNNB1 RPL5 SOD2 | 4.53e-09 | 1203 | 209 | 27 | 29180619 |
| Pubmed | SMC1A SRP72 PTBP1 HP1BP3 SLC25A3 MOGS AFG3L2 PLEC EEFSEC H1-10 FLNA SLC25A5 POLRMT DYRK1A DIS3 SLC25A1 H1-5 RPL5 HERC5 | 5.03e-09 | 601 | 209 | 19 | 33658012 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 6.31e-09 | 5 | 209 | 4 | 12919077 | |
| Pubmed | MLEC NCAM1 SRPRA MCCC2 PTBP1 GSPT2 CPT1C RGPD3 AFG3L2 TJP2 PLEC FLNA FLNB RANGAP1 PDCD6IP SLC25A5 GABBR2 TENM4 ABCE1 ARFGAP1 H1-0 H1-5 CRYBG3 CTNNB1 RPL5 SOD2 | 6.36e-09 | 1139 | 209 | 26 | 36417873 | |
| Pubmed | MYO6 SMC1A PTBP1 DDX6 SLC25A3 NOMO2 DDX18 AFG3L2 RAB27A HYOU1 SLC25A5 CPS1 NOMO1 EGFR ABCE1 SLC25A1 H1-3 RPL5 NOMO3 | 6.91e-09 | 613 | 209 | 19 | 22268729 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH7 RPS6KA3 MCCC2 TTK DDX6 NEK3 CLPB NOMO2 AFG3L2 PLEC CPLANE1 LEO1 SLC25A5 DYRK1A SAR1A NOMO1 ACTR1A EGFR ABCE1 CTNNB1 NOMO3 | 7.91e-09 | 910 | 209 | 23 | 36736316 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 ASXL1 MYH4 MYO6 SMC1A OTUD7B DDX10 CLPB AFG3L2 SHPRH MIOS TJP2 PLEC FLNA FLNB FLNC RANGAP1 DIS3 NPLOC4 ABCE1 GYS1 ANKRD17 USPL1 DCAF4 | 1.09e-08 | 1005 | 209 | 24 | 19615732 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | CMTR1 MYO6 SPART SRPRA RGPD3 FLNA FLNC RANGAP1 CHD8 NR3C1 CPS1 DIS3 NOSIP RESF1 ARFGAP1 SENP6 | 1.41e-08 | 444 | 209 | 16 | 34795231 |
| Pubmed | 1.43e-08 | 14 | 209 | 5 | 33742095 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBL7 IMPDH1 SMC1A RPS6KA3 GBP2 SRP72 PTBP1 GSPT2 UGP2 TJP2 PLEC H1-10 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP LEO1 UBA2 NR3C1 DIS3 NPLOC4 ACTR1B ACTR1A ABCE1 ARFGAP1 PANK4 H1-5 | 1.60e-08 | 1455 | 209 | 29 | 22863883 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SPART HP1BP3 SLC25A3 MOGS DDX18 UGP2 TJP2 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP SLC25A5 NR3C1 DIS3 NPLOC4 NOSIP ACTR1A ABCE1 SLC25A1 ARFGAP1 H1-0 MRPS11 ANKRD17 H1-1 CTNNB1 RPL5 | 1.63e-08 | 1367 | 209 | 28 | 32687490 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | MYO6 SRPRA PTBP1 SLC25A3 GSPT2 DDX18 PLEC H1-10 FLNA FLNB SLC25A5 CPS1 ACTR1A EGFR SLC25A1 H1-3 H1-5 RPL5 | 1.72e-08 | 580 | 209 | 18 | 35676659 |
| Pubmed | 1.88e-08 | 6 | 209 | 4 | 1728586 | ||
| Pubmed | Linker histone transitions during mammalian oogenesis and embryogenesis. | 1.88e-08 | 6 | 209 | 4 | 9499577 | |
| Pubmed | H1 family histones in the nucleus. Control of binding and localization by the C-terminal domain. | 1.88e-08 | 6 | 209 | 4 | 15911621 | |
| Pubmed | Characterization of phosphorylation sites on histone H1 isoforms by tandem mass spectrometry. | 1.88e-08 | 6 | 209 | 4 | 15595731 | |
| Pubmed | Hormone-mediated dephosphorylation of specific histone H1 isoforms. | 1.88e-08 | 6 | 209 | 4 | 11479299 | |
| Pubmed | 1.88e-08 | 6 | 209 | 4 | 19882353 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.88e-08 | 6 | 209 | 4 | 10588881 | |
| Pubmed | Analysis of the Tropism of SARS-CoV-2 Based on the Host Interactome of the Spike Protein. | 2.85e-08 | 31 | 209 | 6 | 37939376 | |
| Pubmed | IMPDH1 MLEC SRP72 SRPRA DDX6 DDX10 SLC25A3 PTPN13 CLPB RGPD3 AFG3L2 MIOS CRYBG1 TAF2 FAR1 SDCBP EEFSEC POLRMT DYRK1A CHD8 CHD7 NOMO1 ACTR1A SETD2 SLC25A1 ANKRD17 PATJ PARD3 AGRN | 2.96e-08 | 1497 | 209 | 29 | 31527615 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | SMC1A SRP72 MCCC2 PGM3 DDX6 CLPB DDX18 HYOU1 PDCD6IP SAR1A DIS3 NPLOC4 ACTR1A ABCE1 SLC25A1 H1-0 H1-5 MRPL46 | 3.43e-08 | 607 | 209 | 18 | 39147351 |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | MYO6 SMC1A SRP72 DDX6 SLC25A3 PLEC FLNA FLNB FLNC HYOU1 PDCD6IP SLC25A5 DIS3 NPLOC4 H1-3 RPL5 | 3.82e-08 | 477 | 209 | 16 | 31300519 |
| Pubmed | DDX6 HP1BP3 MOGS DDX18 AFG3L2 FAR1 ELOA RANGAP1 HYOU1 SLC25A5 POLRMT DIS3 MRPS11 ANKRD17 MRPL46 RPL5 HERC5 | 4.27e-08 | 547 | 209 | 17 | 37267103 | |
| Pubmed | MCCC2 PTPN13 RGPD3 PLEC FAR1 FLNA FLNB POLRMT CHD8 CHD7 MORC4 RESF1 ZNF532 ANKRD17 CRYBG3 | 4.29e-08 | 418 | 209 | 15 | 34709266 | |
| Pubmed | 4.37e-08 | 7 | 209 | 4 | 35210422 | ||
| Pubmed | 4.37e-08 | 7 | 209 | 4 | 16076904 | ||
| Pubmed | All known human H1 histone genes except the H1(0) gene are clustered on chromosome 6. | 4.37e-08 | 7 | 209 | 4 | 8325638 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 4.37e-08 | 7 | 209 | 4 | 29758057 | |
| Pubmed | 4.37e-08 | 7 | 209 | 4 | 16819597 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH4 MYO6 PTBP1 SLC25A3 CRYBG1 PLEC FLNA FLNB SLC25A5 EGFR ANKRD17 | 4.52e-08 | 202 | 209 | 11 | 33005030 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYO6 SMC1A PTBP1 DDX6 CLPB PLEC FLNA FLNB FLNC RANGAP1 LEO1 SLC25A5 UBA2 SAR1A ACTR1A SAR1B H1-3 H1-5 ANKRD17 H1-1 RPL5 | 5.09e-08 | 847 | 209 | 21 | 35235311 |
| Pubmed | MYO6 NCAM1 SRPRA MCCC2 PTBP1 HP1BP3 OTUD7B PTPN13 DDX18 TJP2 PDCD6IP APOB SAR1A LRIG3 LIPE EGFR SAR1B ARFGAP1 CGNL1 PARD3 | 5.89e-08 | 777 | 209 | 20 | 35844135 | |
| Pubmed | MYH2 MLEC MYO6 MIB1 TAF2 PDCD6IP CHD7 NR3C1 MORC4 SAR1A NOSIP WDR19 ABCE1 DDHD1 GYS1 ANKRD17 NOMO3 DNAH11 | 7.23e-08 | 638 | 209 | 18 | 31182584 | |
| Pubmed | USP53 plays an antitumor role in hepatocellular carcinoma through deubiquitination of cytochrome c. | 7.56e-08 | 90 | 209 | 8 | 35654790 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | SMC1A SRP72 DDX6 SLC25A3 MOGS CLPB NOMO2 FAR1 SDCBP RANGAP1 SLC25A5 GNB1L DIS3 NPLOC4 FLAD1 CTNNB1 PATJ | 7.89e-08 | 571 | 209 | 17 | 37167062 |
| Pubmed | 8.70e-08 | 8 | 209 | 4 | 26993635 | ||
| Pubmed | CMTR1 SMC1A SPART SRP72 MCCC2 PTBP1 DDX6 MOGS CLPB DDX18 FLNA LEO1 DIS3 NOSIP ABCE1 GYS1 PANK4 CTNNB1 | 1.02e-07 | 653 | 209 | 18 | 33742100 | |
| Pubmed | KCTD9 SMC1A SRP72 PTBP1 DDX6 HP1BP3 SLC25A3 DDX18 PLEC H1-10 FLNA FLNC SLC25A5 POLRMT ABCE1 H1-0 H1-3 CTNNB1 MRPL46 RPL5 | 1.13e-07 | 809 | 209 | 20 | 32129710 | |
| Pubmed | MBP PGM3 HP1BP3 MOGS MIOS PDCD6IP UBA2 CPS1 DIS3 NPLOC4 ABCE1 GYS1 PANK4 H1-3 CTNNB1 | 1.15e-07 | 451 | 209 | 15 | 36168627 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SMC1A RPS6KA3 HP1BP3 GSPT2 DDX18 RGPD3 FAR1 FLNB RANGAP1 HYOU1 PDCD6IP LEO1 SLC25A5 ACTR1B ACTR1A ABCE1 H1-0 RPL5 | 1.34e-07 | 665 | 209 | 18 | 30457570 |
| Pubmed | 1.56e-07 | 9 | 209 | 4 | 31960486 | ||
| Pubmed | RPS6KA3 PTPN13 CCSER2 TJP2 CRYBG1 PLEC CPLANE1 FLNA FLNB HYOU1 PDCD6IP DYRK1A APOB CHD7 DIS3 RESF1 ABCE1 DDHD1 ARFGAP1 ANKRD17 PATJ PARD3 AGRN | 1.87e-07 | 1084 | 209 | 23 | 11544199 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 12393796 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 21470888 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 11153914 | ||
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 2.14e-07 | 3 | 209 | 3 | 26059207 | |
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 36011023 | ||
| Pubmed | 2.14e-07 | 3 | 209 | 3 | 11252955 | ||
| Pubmed | Structural and developmental analysis of two linked myosin heavy chain genes. | 2.14e-07 | 3 | 209 | 3 | 1371481 | |
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 2.14e-07 | 3 | 209 | 3 | 25576386 | |
| Pubmed | High-throughput kinase assays with protein substrates using fluorescent polymer superquenching. | 2.59e-07 | 10 | 209 | 4 | 15927069 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SMC1A SPICE1 OTUD7B PASK TJP2 PLEC H1-10 FLNA ELOA RANGAP1 LEO1 UBA2 CHD7 SETD2 EGFR ARFGAP1 SENP6 ANKRD17 PARD3 | 2.65e-07 | 774 | 209 | 19 | 15302935 |
| Pubmed | 2.70e-07 | 191 | 209 | 10 | 33762435 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | SMC1A SRPRA PTBP1 DDX6 SLC25A3 MOGS DDX18 AFG3L2 FAR1 H1-10 SLC25A5 ABCE1 SLC25A1 RPL5 HERC5 | 2.98e-07 | 486 | 209 | 15 | 30940648 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DYRK4 TTK DDX6 SPICE1 PTPN13 CCSER2 TJP2 FNIP1 PLEC PDCD6IP DYRK1A VPS13D RESF1 SLC25A1 ARFGAP1 ANKRD17 CGNL1 CRYBG3 PATJ PARD3 | 3.03e-07 | 861 | 209 | 20 | 36931259 |
| Pubmed | MYO6 SMC1A SPART SRPRA MCCC2 EIPR1 PGM3 SLC25A3 MOGS NOMO2 AFG3L2 ELOA RANGAP1 LEO1 UBA2 PANK4 | 3.34e-07 | 560 | 209 | 16 | 35241646 | |
| Pubmed | SMC1A SRP72 PTBP1 DDX6 HP1BP3 PLEC FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP DYRK1A CTNNB1 RPL5 | 3.67e-07 | 494 | 209 | 15 | 26831064 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYO6 TTK DDX6 CCSER2 TJP2 CRYBG1 PLEC SDCBP H1-10 FLNA FLNB RANGAP1 EGFR CTNNB1 PATJ PARD3 | 3.76e-07 | 565 | 209 | 16 | 25468996 |
| Pubmed | SPART SRP72 SRPRA TTK RGPD3 RAB27A FLNA FLNB FLNC RANGAP1 NPLOC4 ORC2 VPS13D EGFR SAR1B ARFGAP1 | 4.03e-07 | 568 | 209 | 16 | 37774976 | |
| Pubmed | 4.05e-07 | 11 | 209 | 4 | 18310078 | ||
| Pubmed | The histone code reader Spin1 controls skeletal muscle development. | 4.05e-07 | 11 | 209 | 4 | 29168801 | |
| Pubmed | MLEC SPART SLC25A3 DDX18 FLNA FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 UBA2 NR3C1 SAR1A DIS3 SLC25A1 FLAD1 ARFGAP1 H1-3 H1-5 H1-1 | 4.11e-07 | 878 | 209 | 20 | 37223481 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | RPS6KA3 PKDREJ SLC25A3 H1-10 SLC25A5 APOB EGFR SLC25A1 H1-3 H1-1 CTNNB1 | 4.90e-07 | 256 | 209 | 11 | 24189400 |
| Interaction | KCNA3 interactions | CMTR1 MLEC MYO6 SMC1A SPART SRP72 SRPRA PTBP1 TTK DDX6 SPICE1 SLC25A3 PTPN13 AFG3L2 FAR1 FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 GNB1L HELQ NPLOC4 EGFR ABCE1 ARFGAP1 SENP6 ANKRD17 CRYBG3 PATJ PARD3 RPL5 | 3.61e-10 | 871 | 207 | 32 | int:KCNA3 |
| Interaction | H3C1 interactions | MYO6 SMC1A RPS6KA3 SRP72 HP1BP3 DDX10 ZNF512B MOGS DDX18 SHPRH TAF2 H1-10 ELOA LEO1 KAT6A DYRK1A CHD8 CHD7 NR3C1 DNAH1 ORC2 SETD2 EGFR WDR87 H1-0 H1-3 H1-5 SENP6 H1-1 CTNNB1 RPL5 | 3.37e-09 | 901 | 207 | 31 | int:H3C1 |
| Interaction | BTF3 interactions | MYH2 MYH7 MYO6 PTBP1 DDX6 SPICE1 SLC25A3 DDX18 RGPD3 MIB1 TJP2 PLEC FLNA FLNB PDCD6IP SLC25A5 POLRMT CHD7 SAR1A C4orf54 ACTR1A EGFR SAR1B H1-0 H1-5 KIF4B H1-1 CTNNB1 RPL5 | 3.49e-09 | 799 | 207 | 29 | int:BTF3 |
| Interaction | NR2C2 interactions | SMC1A RPS6KA3 SRP72 SRPRA MCCC2 PTBP1 TTK DDX6 HP1BP3 DDX10 SLC25A3 DDX18 AFG3L2 MIB1 TJP2 CRYBG1 PLEC FAR1 H1-10 FLNA HYOU1 PDCD6IP SLC25A5 UBA2 CHD8 CHD7 DIS3 ORC2 ABCE1 SLC25A1 GYS1 H1-0 H1-3 H1-5 MRPS11 AGRN RPL5 | 1.02e-07 | 1403 | 207 | 37 | int:NR2C2 |
| Interaction | AGR2 interactions | MLEC GBP3 MCCC2 PTBP1 DDX6 HP1BP3 MOGS DDX18 PLEC H1-10 FLNA FLNB FLNC HYOU1 PDCD6IP SLC25A5 MUC19 CHD8 SAR1A DNAH1 ACTR1A ABCE1 SLC25A1 SAR1B H1-0 H1-3 H1-5 AGRN RPL5 | 1.06e-07 | 934 | 207 | 29 | int:AGR2 |
| Interaction | USP53 interactions | HP1BP3 SLC25A3 DDX18 TJP2 PLEC ELOA FLNC PDCD6IP ANKRD17 CTNNB1 RPL5 | 1.90e-07 | 138 | 207 | 11 | int:USP53 |
| Interaction | NCL interactions | KCTD9 ASXL1 CMTR1 SMC1A RPS6KA3 SPART SRP72 PTBP1 DDX6 MOGS DDX18 H1-10 FLNA FLNB RANGAP1 SLC25A5 NR3C1 SETD2 EGFR WDR87 SLC25A1 H1-3 H1-5 H1-1 CTNNB1 RPL5 | 2.05e-07 | 798 | 207 | 26 | int:NCL |
| Interaction | MCM2 interactions | MYH1 MYH2 MYH4 MLEC SMC1A SRP72 PTBP1 DDX6 SLC25A3 MOGS CLPB RGPD3 UGP2 TJP2 PLEC FLNA FLNB FLNC HYOU1 SLC25A5 NPLOC4 DNAH1 NOSIP ORC2 EGFR ABCE1 SLC25A1 H1-0 H1-1 CTNNB1 RPL5 | 2.13e-07 | 1081 | 207 | 31 | int:MCM2 |
| Interaction | NPM1 interactions | ASXL1 MYH7 TRMT10B CMTR1 RPS6KA3 SRP72 PTBP1 HP1BP3 DDX10 SLC25A3 MOGS DDX18 H1-10 FLNA FLNB FLNC SLC25A5 KAT6A POLRMT DYRK1A CHD8 SETD2 EGFR WDR87 H1-3 H1-5 H1-1 CTNNB1 MRPL46 AGRN RPL5 DCAF4 HERC5 | 2.20e-07 | 1201 | 207 | 33 | int:NPM1 |
| Interaction | PARP1 interactions | MORC1 IMPDH1 CMTR1 SMC1A PGM3 DDX6 HP1BP3 DDX10 ZNF512B NEK3 PTPN13 CLPB DDX18 SHPRH ELOA RANGAP1 HYOU1 PDCD6IP LEO1 UBA2 CHD7 NR3C1 EGFR SLC25A1 ARFGAP1 H1-0 H1-3 H1-5 SENP6 H1-1 CGNL1 CTNNB1 AGRN RPL5 | 5.85e-07 | 1316 | 207 | 34 | int:PARP1 |
| Interaction | EED interactions | ASXL1 MYO6 SMC1A MCCC2 PTBP1 DDX6 HP1BP3 DDX10 ZNF512B SLC25A3 MOGS DDX18 SHPRH TJP2 PLEC FAR1 H1-10 FLNA FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 SFTPD UBA2 CHD7 DIS3 ACTR1A ABCE1 SAR1B H1-0 H1-1 CGNL1 CTNNB1 AGRN RPL5 | 6.15e-07 | 1445 | 207 | 36 | int:EED |
| Interaction | WDR5 interactions | ASXL1 SRP72 SRPRA MCCC2 PTBP1 TTK DDX6 SLC25A3 PASK MOGS DDX18 TJP2 PLEC EEFSEC H1-10 FLNA FLNB HYOU1 PDCD6IP SLC25A5 KAT6A CHD8 CHD7 ACTR1A ABCE1 ARFGAP1 H1-1 CTNNB1 MRPL46 RPL5 | 9.98e-07 | 1101 | 207 | 30 | int:WDR5 |
| Interaction | MAP3K14 interactions | OTUD7B SLC25A3 DDX18 H1-10 SLC25A5 POLRMT EGFR SLC25A1 H1-0 RPL5 HERC5 | 1.44e-06 | 169 | 207 | 11 | int:MAP3K14 |
| Interaction | CIT interactions | MYO6 SMC1A SRP72 SRPRA PTBP1 HP1BP3 DDX10 SLC25A3 TYRP1 BPI MOGS CLPB DDX18 RGPD3 TJP2 PLEC H1-10 FLNA FLNB FLNC RANGAP1 DYRK1A CHD8 APOB CPS1 ORC2 ACTR1B SLC25A1 PANK4 H1-3 H1-5 CTNNB1 PATJ PARD3 RPL5 | 1.86e-06 | 1450 | 207 | 35 | int:CIT |
| Interaction | NUP43 interactions | SMC1A CCDC168 MCCC2 HP1BP3 DDX18 CCSER2 TAF2 H1-10 FLNA RANGAP1 LEO1 MUC19 CHD8 SETD2 RESF1 EGFR ZNF532 H1-0 SENP6 H1-1 RPL5 | 2.04e-06 | 625 | 207 | 21 | int:NUP43 |
| Interaction | SIRT7 interactions | SRP72 HP1BP3 DDX10 DDX18 TJP2 PLEC H1-10 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP POLRMT CHD8 CHD7 DIS3 ABCE1 H1-3 ANKRD17 H1-1 RPL5 HERC5 | 2.64e-06 | 744 | 207 | 23 | int:SIRT7 |
| Interaction | CYLD interactions | MYO6 COL6A5 PTBP1 HP1BP3 SLC25A3 AFG3L2 MIB1 PLEC FAR1 H1-10 FLNA FLNC RANGAP1 HYOU1 SLC25A5 MUC19 DYRK1A ACTR1B ACTR1A EGFR H1-0 CTNNB1 MRPL46 PARD3 RPL5 | 3.33e-06 | 868 | 207 | 25 | int:CYLD |
| Interaction | IPO7 interactions | ASXL1 HP1BP3 SPICE1 SLC25A3 H1-10 RANGAP1 NR3C1 NOSIP EGFR SLC25A1 H1-0 H1-5 RPL5 DCAF4 | 3.35e-06 | 304 | 207 | 14 | int:IPO7 |
| Interaction | CAPZB interactions | UBL7 MYO6 SPART DDX6 CLPB TJP2 TAF2 FAR1 H1-10 FLNA FLNB FLNC LEO1 SLC25A5 DYRK1A UBA2 NOSIP ACTR1B ACTR1A EGFR ABCE1 SLC25A1 H1-0 ANKRD17 MRPL46 PATJ RPL5 DCAF4 | 3.54e-06 | 1049 | 207 | 28 | int:CAPZB |
| Interaction | SERBP1 interactions | CMTR1 MLEC RPS6KA3 SPART SRP72 DDX6 DDX10 SLC25A3 DDX18 TJP2 FLNA ELOA FLNB RANGAP1 HYOU1 PDCD6IP SLC25A5 KAT6A UBA2 NR3C1 SAR1A DIS3 EGFR SLC25A1 FLAD1 ARFGAP1 H1-3 H1-5 ANKRD17 H1-1 CTNNB1 MRPL46 RPL5 HERC5 | 3.84e-06 | 1432 | 207 | 34 | int:SERBP1 |
| Interaction | JCAD interactions | 4.21e-06 | 42 | 207 | 6 | int:JCAD | |
| Interaction | DDRGK1 interactions | SRP72 SRPRA EIPR1 PTBP1 DDX6 HP1BP3 DDX10 SLC25A3 GSPT2 MOGS DDX18 AFG3L2 SHPRH TJP2 PLG SDCBP EEFSEC H1-10 ELOA RANGAP1 SLC25A5 GNB1L POLRMT DIS3 NOSIP SLC25A1 H1-0 H1-3 MRPL46 RPL5 HERC5 | 4.49e-06 | 1249 | 207 | 31 | int:DDRGK1 |
| Interaction | FBXO6 interactions | MYO6 SMC1A PTBP1 DDX6 SLC25A3 NOMO2 DDX18 AFG3L2 RAB27A HYOU1 SLC25A5 CPS1 NOMO1 TENM4 EGFR ABCE1 SLC25A1 ENTPD2 H1-3 AGRN RPL5 NOMO3 | 4.98e-06 | 717 | 207 | 22 | int:FBXO6 |
| Interaction | G3BP1 interactions | CMTR1 MYO6 SRPRA PTBP1 DDX6 SLC25A3 DDX18 RGPD3 AFG3L2 TJP2 CRYBG1 H1-10 FLNA FLNB PDCD6IP NOSIP ACTR1B ACTR1A EGFR SLC25A1 H1-0 ANKRD17 CTNNB1 RPL5 | 5.49e-06 | 835 | 207 | 24 | int:G3BP1 |
| Interaction | BIRC3 interactions | MLEC SMC1A SRP72 MCCC2 PTBP1 DDX6 DDX10 SLC25A3 MOGS CLPB DDX18 FAR1 SDCBP H1-10 FLNA FLNB RANGAP1 RIPK3 HYOU1 PDCD6IP SLC25A5 GNB1L POLRMT APOB SAR1A DIS3 NOMO1 ACTR1A EGFR ABCE1 H1-0 RPL5 | 6.25e-06 | 1334 | 207 | 32 | int:BIRC3 |
| Interaction | HNRNPU interactions | KCTD9 ASXL1 CMTR1 SMC1A RPS6KA3 SRP72 PTBP1 DDX6 HP1BP3 DDX18 CPLANE1 EEFSEC H1-10 SLC25A5 KAT6A NR3C1 DNAH1 ACTR1A EGFR H1-0 H1-5 MRPS11 H1-1 CTNNB1 MRPL46 RPL5 HERC5 | 8.16e-06 | 1035 | 207 | 27 | int:HNRNPU |
| Interaction | RUFY1 interactions | SRP72 MCCC2 PTBP1 PGM3 SLC25A3 MOGS FAR1 H1-10 FLNA RANGAP1 PDCD6IP SLC25A5 UBA2 SLC25A1 H1-0 H1-5 H1-1 | 9.12e-06 | 476 | 207 | 17 | int:RUFY1 |
| Interaction | LRRC31 interactions | MYH4 MYO6 PTBP1 SLC25A3 CRYBG1 PLEC FLNA FLNB SLC25A5 EGFR ANKRD17 | 9.29e-06 | 205 | 207 | 11 | int:LRRC31 |
| Interaction | FGD5 interactions | 1.02e-05 | 207 | 207 | 11 | int:FGD5 | |
| Interaction | ARHGAP24 interactions | MBP PGM3 HP1BP3 MOGS MIB1 MIOS FLNA PDCD6IP UBA2 CPS1 DIS3 NPLOC4 ABCE1 GYS1 PANK4 H1-3 CTNNB1 | 1.19e-05 | 486 | 207 | 17 | int:ARHGAP24 |
| Interaction | RAPGEF2 interactions | 1.29e-05 | 105 | 207 | 8 | int:RAPGEF2 | |
| Interaction | DLST interactions | IMPDH1 MLEC MYO6 HP1BP3 CLPB PLEC H1-10 ELOA RANGAP1 HYOU1 PDCD6IP SLC25A5 NR3C1 EGFR H1-0 MRPS11 SOD2 | 1.33e-05 | 490 | 207 | 17 | int:DLST |
| Interaction | C9orf72 interactions | MLEC MYO6 SMC1A SPART SRPRA MCCC2 PTBP1 PGM3 DDX6 SLC25A3 CLPB NOMO2 RGPD3 AFG3L2 FAR1 H1-10 RANGAP1 SLC25A5 MORC4 DIS3 NPLOC4 NOMO1 ACTR1A ABCE1 SLC25A1 PANK4 H1-3 H1-1 CTNNB1 RPL5 NOMO3 | 1.33e-05 | 1319 | 207 | 31 | int:C9orf72 |
| Interaction | RPL4 interactions | GBP2 SRP72 SRPRA DDX6 HP1BP3 DDX10 DDX18 H1-10 SLC25A5 KAT6A POLRMT SAR1A EGFR ABCE1 SAR1B H1-5 MRPS11 H1-1 CTNNB1 RPL5 NOMO3 HERC5 | 1.35e-05 | 764 | 207 | 22 | int:RPL4 |
| Interaction | CDK7 interactions | MORC1 MLEC MBP PTBP1 DDX10 SLC25A3 TAF2 SDCBP H1-10 ELOA SLC25A5 EGFR SLC25A1 H1-0 H1-3 H1-1 RPL5 | 1.76e-05 | 501 | 207 | 17 | int:CDK7 |
| Interaction | WWP2 interactions | UBL7 SMC1A SPART SRP72 MCCC2 PTBP1 DDX6 HP1BP3 OTUD7B SLC25A3 DDX18 H1-10 FLNA PDCD6IP SLC25A5 SLC25A1 GYS1 H1-0 ANKRD17 H1-1 CTNNB1 PATJ RPL5 | 1.89e-05 | 840 | 207 | 23 | int:WWP2 |
| Interaction | ASAH2 interactions | 2.09e-05 | 6 | 207 | 3 | int:ASAH2 | |
| Interaction | LMNA interactions | CMTR1 SMC1A SRPRA HP1BP3 ZNF512B MOGS DDX18 UGP2 SDCBP RAB27B FLNA ELOA RANGAP1 SLC25A5 CHD8 SAR1A DIS3 NPLOC4 NOSIP ORC2 EGFR ABCE1 SLC25A1 H1-0 H1-5 SENP6 CFAP74 H1-1 CTNNB1 RPL5 | 2.15e-05 | 1286 | 207 | 30 | int:LMNA |
| Interaction | H3-5 interactions | 2.35e-05 | 114 | 207 | 8 | int:H3-5 | |
| Interaction | NAA40 interactions | MYO6 SPART HP1BP3 DDX10 ZNF512B SLC25A3 PTPN13 AFG3L2 SDCBP FLNA ELOA RANGAP1 NR3C1 DIS3 NPLOC4 ORC2 SETD2 ABCE1 ARFGAP1 SENP6 ANKRD17 CGNL1 SCIN RPL5 HERC5 | 2.55e-05 | 978 | 207 | 25 | int:NAA40 |
| Interaction | HDGF interactions | SRP72 HP1BP3 SLC25A3 H1-10 FLNB SLC25A5 POLRMT EGFR H1-0 H1-3 H1-1 CTNNB1 AGRN | 2.94e-05 | 321 | 207 | 13 | int:HDGF |
| Interaction | YWHAQ interactions | KCTD9 MYH2 MYH7 RPS6KA3 DDX6 KANK1 PTPN13 CLPB CCSER2 TJP2 PLEC PLG FLNA REM1 DYRK1A CPS1 VPS13D EGFR SLC25A1 FSHR H1-0 H1-3 ANKRD17 H1-1 CGNL1 CTNNB1 PARD3 | 3.20e-05 | 1118 | 207 | 27 | int:YWHAQ |
| Interaction | EFTUD2 interactions | ASXL1 SMC1A SRP72 SRPRA PTBP1 DDX6 HP1BP3 SLC25A3 MOGS DDX18 AFG3L2 PLEC SDCBP EEFSEC H1-10 FLNA FLNB RANGAP1 PDCD6IP LEO1 SLC25A5 GNB1L CPS1 DIS3 NPLOC4 NOSIP EGFR SLC25A1 H1-5 CTNNB1 MRPL46 RPL5 | 3.26e-05 | 1449 | 207 | 32 | int:EFTUD2 |
| Interaction | SAE1 interactions | 3.30e-05 | 155 | 207 | 9 | int:SAE1 | |
| Interaction | ANKRD36B interactions | 3.45e-05 | 60 | 207 | 6 | int:ANKRD36B | |
| Interaction | RPS24 interactions | CMTR1 SRP72 CCDC168 DDX6 HP1BP3 DDX10 MOGS DDX18 H1-10 ELOA SLC25A5 KAT6A DYRK1A EGFR H1-1 CTNNB1 RPL5 | 3.51e-05 | 529 | 207 | 17 | int:RPS24 |
| Interaction | SQSTM1 interactions | MYO6 MBP SPART GBP2 SRP72 SRPRA TTK OTUD7B SLC25A3 KANK1 GSPT2 MOGS CLPB MIB1 MIOS SDCBP FLNA FLNB KAT6A POLRMT DYRK1A ACTR1A SLC25A1 SAR1B ARFGAP1 MRPS11 CTNNB1 PARD3 RPL5 | 3.66e-05 | 1257 | 207 | 29 | int:SQSTM1 |
| Interaction | SMC5 interactions | MYH1 MYH4 SMC1A SRP72 PTBP1 HP1BP3 DDX10 ZNF512B SLC25A3 DDX18 H1-10 FLNA ELOA RANGAP1 SLC25A5 UBA2 CHD8 CHD7 NOSIP ORC2 SETD2 H1-5 SENP6 H1-1 RPL5 | 3.67e-05 | 1000 | 207 | 25 | int:SMC5 |
| Interaction | GBP6 interactions | 3.71e-05 | 19 | 207 | 4 | int:GBP6 | |
| Interaction | SRP9 interactions | SRP72 SRPRA DDX6 HP1BP3 DDX18 H1-10 LEO1 CHD8 EGFR ABCE1 ANKRD17 CTNNB1 RPL5 NOMO3 HERC5 | 3.76e-05 | 427 | 207 | 15 | int:SRP9 |
| Interaction | RPL10 interactions | CMTR1 SRP72 SRPRA DDX6 HP1BP3 DDX10 SLC25A3 DDX18 CRYBG1 H1-10 KAT6A POLRMT EGFR H1-5 MRPS11 ANKRD17 CTNNB1 MRPL46 RPL5 HERC5 | 3.94e-05 | 702 | 207 | 20 | int:RPL10 |
| Interaction | ABCE1 interactions | IMPDH1 MYO6 SMC1A RPS6KA3 SRP72 DDX6 DDX18 FLNA FLNB DYRK1A NR3C1 EGFR ABCE1 CTNNB1 RPL5 | 4.18e-05 | 431 | 207 | 15 | int:ABCE1 |
| Interaction | NF2 interactions | SMC1A SRPRA SLC25A3 AFG3L2 SDCBP PDCD6IP SLC25A5 HELQ CBR4 EGFR SLC25A1 CTNNB1 PARD3 USPL1 | 4.46e-05 | 383 | 207 | 14 | int:NF2 |
| Interaction | RPL11 interactions | CMTR1 SMC1A SRP72 DDX6 HP1BP3 DDX10 DDX18 H1-10 LEO1 SLC25A5 KAT6A UBA2 CHD7 EGFR ARFGAP1 ANKRD17 CTNNB1 RPL5 DCAF4 | 4.58e-05 | 652 | 207 | 19 | int:RPL11 |
| Interaction | RECQL4 interactions | MYO6 SRP72 MCCC2 PTBP1 TTK DDX6 HP1BP3 SLC25A3 PASK MOGS CLPB AFG3L2 PLEC H1-10 RANGAP1 HYOU1 SLC25A5 POLRMT NPLOC4 NOSIP ORC2 ACTR1A RESF1 WDR87 FLAD1 GYS1 H1-0 MRPS11 H1-1 MRPL46 RPL5 | 4.91e-05 | 1412 | 207 | 31 | int:RECQL4 |
| Interaction | KPNB1 interactions | KCTD9 ASXL1 SPART HP1BP3 MOGS H1-10 RANGAP1 DYRK1A CHD8 NR3C1 DIS3 NOSIP EGFR SLC25A1 H1-0 CTNNB1 RPL5 | 4.96e-05 | 544 | 207 | 17 | int:KPNB1 |
| Interaction | TNIP1 interactions | MYO6 SMC1A SRP72 PTBP1 HP1BP3 DDX10 SLC25A3 GSPT2 DDX18 MIB1 TAF2 PLEC SDCBP H1-10 FLNA ELOA FLNB RANGAP1 SLC25A5 APOB CPS1 ACTR1A SLC25A1 H1-0 H1-3 H1-5 RPL5 HERC5 | 5.30e-05 | 1217 | 207 | 28 | int:TNIP1 |
| Interaction | CDC27 interactions | 5.60e-05 | 249 | 207 | 11 | int:CDC27 | |
| Interaction | OBSL1 interactions | SMC1A PTBP1 DDX6 HP1BP3 DDX10 SLC25A3 PASK DDX18 TJP2 FNIP1 PLEC H1-10 FLNA FLNB FLNC RANGAP1 SLC25A5 DYRK1A DNAH1 H1-0 CTNNB1 SCIN RPL5 | 5.70e-05 | 902 | 207 | 23 | int:OBSL1 |
| Interaction | RPS3 interactions | ASXL1 SRP72 DDX6 HP1BP3 DDX10 EEFSEC SLC25A5 KAT6A POLRMT SAR1A EGFR SAR1B H1-3 H1-5 H1-1 CTNNB1 PARD3 AGRN RPL5 DCAF4 | 5.70e-05 | 721 | 207 | 20 | int:RPS3 |
| Interaction | PHF21A interactions | MCCC2 EIPR1 PTPN13 PLEC FAR1 FLNA FLNB POLRMT CHD8 CHD7 MORC4 RESF1 CRYBG3 | 5.81e-05 | 343 | 207 | 13 | int:PHF21A |
| Interaction | YAP1 interactions | MYO6 MCCC2 PTBP1 DDX6 OTUD7B SLC25A3 PTPN13 TJP2 TAF2 PLEC SDCBP H1-10 FLNA FLNB RANGAP1 HYOU1 SLC25A5 UBA2 CHD8 SETD2 EGFR ARFGAP1 H1-5 CTNNB1 PATJ PARD3 | 6.00e-05 | 1095 | 207 | 26 | int:YAP1 |
| Interaction | EGLN3 interactions | KCTD9 MYO6 SMC1A MCCC2 TTK PGM3 SLC25A3 PASK PTPN13 CLPB AFG3L2 MIB1 CCSER2 MIOS FAR1 RANGAP1 SLC25A5 GNB1L DYRK1A CHD8 NPLOC4 NOSIP ABCE1 SLC25A1 DDHD1 PANK4 ANKRD17 CTNNB1 PARD3 | 6.32e-05 | 1296 | 207 | 29 | int:EGLN3 |
| Interaction | TTN interactions | SMC1A UGP2 FLNA HYOU1 NR3C1 EGFR ZNF532 SAR1B H1-5 H1-1 PARD3 AGRN | 6.52e-05 | 299 | 207 | 12 | int:TTN |
| Interaction | RFPL2 interactions | 6.84e-05 | 22 | 207 | 4 | int:RFPL2 | |
| Interaction | H1-0 interactions | SMC1A HP1BP3 H1-10 DYRK1A CHD8 H1-0 H1-3 H1-5 H1-1 RPL5 DCAF4 | 7.18e-05 | 256 | 207 | 11 | int:H1-0 |
| Interaction | HDAC1 interactions | MYH1 MYH2 MYH4 MYH7 SMC1A SRPRA MCCC2 ZNF512B SLC25A3 PTPN13 PLEC FAR1 FLNA FLNB SLC25A5 POLRMT CHD8 NR3C1 MORC4 ACTR1A EGFR ANKRD17 H1-1 CRYBG3 CTNNB1 HERC5 | 7.28e-05 | 1108 | 207 | 26 | int:HDAC1 |
| Interaction | CEBPB interactions | IMPDH1 SMC1A RPS6KA3 SPART SRP72 PTBP1 DDX6 HP1BP3 SLC25A3 DDX18 PLEC SDCBP H1-10 FLNA FLNB RANGAP1 HYOU1 LEO1 UBA2 CHD7 NR3C1 DIS3 NOSIP EGFR ABCE1 ARFGAP1 PANK4 H1-3 H1-5 RPL5 SOD2 | 7.36e-05 | 1443 | 207 | 31 | int:CEBPB |
| Interaction | PINK1 interactions | MYO6 SMC1A SRP72 DDX6 SLC25A3 CLPB PLEC PLG FLNA FLNB FLNC HYOU1 PDCD6IP SLC25A5 DIS3 NPLOC4 SAR1B H1-3 RPL5 | 7.84e-05 | 679 | 207 | 19 | int:PINK1 |
| Interaction | SPRING1 interactions | MOGS CLPB MIB1 UGP2 ELOA PDCD6IP DYRK1A SAR1A SETD2 SLC25A1 SOD2 | 7.97e-05 | 259 | 207 | 11 | int:SPRING1 |
| Interaction | BAP1 interactions | ASXL1 MYH7 MYO6 SMC1A SPART PTBP1 UGP2 PLEC H1-10 FLNA FLNB FLNC RANGAP1 HYOU1 PDCD6IP UBA2 NR3C1 CPS1 MORC4 ACTR1A LIPT1 EGFR GYS1 PANK4 ANKRD17 CTNNB1 PATJ USPL1 RPL5 | 8.06e-05 | 1314 | 207 | 29 | int:BAP1 |
| Interaction | SLC39A3 interactions | 8.29e-05 | 70 | 207 | 6 | int:SLC39A3 | |
| Interaction | KIF20A interactions | MYO6 PTBP1 DDX18 RGPD3 TJP2 PIP5K1B PLEC FLNA FLNB FLNC POLRMT DYRK1A CHD8 APOB KIAA1586 CPS1 ACTR1B H1-3 H1-5 H1-1 CRYBG3 CTNNB1 PARD3 SCIN RPL5 | 8.30e-05 | 1052 | 207 | 25 | int:KIF20A |
| Interaction | PTEN interactions | UBL7 MCCC2 SLC25A3 PTPN13 MOGS AFG3L2 CRYBG1 PLEC SDCBP EEFSEC FLNA FLNB RANGAP1 SLC25A5 NR3C1 SAR1A EGFR SLC25A1 H1-0 CTNNB1 USPL1 AGRN RPL5 | 8.88e-05 | 929 | 207 | 23 | int:PTEN |
| Interaction | HDAC6 interactions | UBL7 MYO6 SRPRA PTBP1 SPICE1 SLC25A3 NEK3 GSPT2 DDX18 PLEC H1-10 FLNA FLNB SLC25A5 NR3C1 CPS1 ACTR1A EGFR SLC25A1 H1-3 H1-5 CTNNB1 RPL5 | 8.88e-05 | 929 | 207 | 23 | int:HDAC6 |
| Interaction | CTCF interactions | SMC1A SRP72 EIPR1 HP1BP3 SLC25A3 H1-10 SLC25A5 KAT6A POLRMT CHD8 CHD7 ABCE1 H1-3 H1-1 RPL5 | 8.90e-05 | 461 | 207 | 15 | int:CTCF |
| Interaction | SLX4 interactions | CMTR1 SMC1A SPART PTBP1 ZNF512B DDX18 RGPD3 FLNA ELOA RANGAP1 PDCD6IP SLC25A5 DYRK1A CHD8 RESF1 H1-0 SENP6 | 9.17e-05 | 572 | 207 | 17 | int:SLX4 |
| Interaction | SOCS1 interactions | 9.24e-05 | 177 | 207 | 9 | int:SOCS1 | |
| Interaction | H1-5 interactions | CMTR1 CCDC168 HP1BP3 DDX10 METTL25 H1-10 RIPK3 HYOU1 WDR87 DNAH17 H1-0 H1-3 H1-5 H1-1 HERC5 | 9.33e-05 | 463 | 207 | 15 | int:H1-5 |
| Interaction | AMOT interactions | SMC1A SPICE1 PTPN13 CCSER2 TJP2 PLG FLNA MYOM3 CRYBG3 CTNNB1 PATJ PARD3 | 9.76e-05 | 312 | 207 | 12 | int:AMOT |
| Interaction | ATP1A1 interactions | KCTD9 ASXL1 PTBP1 DYRK4 SLC25A3 GSPT2 AFG3L2 FLNA FLNB SLC25A5 NR3C1 CPS1 EGFR SLC25A1 MRPS11 CTNNB1 PARD3 | 9.77e-05 | 575 | 207 | 17 | int:ATP1A1 |
| Interaction | MCM7 interactions | ASXL1 SMC1A MIB1 TJP2 HYOU1 SAR1A ORC2 ACTR1B ACTR1A EGFR SLC25A1 SAR1B H1-0 CTNNB1 | 1.02e-04 | 414 | 207 | 14 | int:MCM7 |
| Interaction | BRD7 interactions | SMC1A SRPRA PTBP1 DDX6 SLC25A3 PTPN13 MOGS DDX18 AFG3L2 FAR1 H1-10 SLC25A5 CHD7 ABCE1 SLC25A1 H1-0 RPL5 HERC5 | 1.08e-04 | 637 | 207 | 18 | int:BRD7 |
| Interaction | FBXL6 interactions | DDX6 HP1BP3 MOGS DDX18 AFG3L2 FAR1 ELOA RANGAP1 HYOU1 SLC25A5 POLRMT DIS3 MRPS11 ANKRD17 MRPL46 RPL5 HERC5 | 1.15e-04 | 583 | 207 | 17 | int:FBXL6 |
| Interaction | RNF4 interactions | IMPDH1 MLEC NCAM1 PTBP1 HP1BP3 SLC25A3 MOGS DDX18 AFG3L2 CCSER2 TAF2 PLEC FAR1 RAB27A H1-10 FLNA ELOA FLNC RANGAP1 SLC25A5 DYRK1A CHD8 ORC2 ZNF532 GYS1 H1-0 H1-1 CTNNB1 RPL5 SOD2 | 1.19e-04 | 1412 | 207 | 30 | int:RNF4 |
| Interaction | SEC61B interactions | MYH7 MLEC SRP72 SRPRA SLC25A3 MOGS NOMO2 AFG3L2 MIB1 H1-10 RANGAP1 HYOU1 SLC25A5 APOB SAR1A NPLOC4 EGFR SAR1B ARFGAP1 RPL5 | 1.23e-04 | 763 | 207 | 20 | int:SEC61B |
| Interaction | SUZ12 interactions | PTBP1 ARMCX1 HP1BP3 ZNF512B DDX18 AFG3L2 SHPRH PLEC PLG H1-10 FLNB PDCD6IP CHD8 CHD7 MORC4 H1-0 H1-3 H1-1 | 1.23e-04 | 644 | 207 | 18 | int:SUZ12 |
| Interaction | FBXW7 interactions | SMC1A SRP72 PTBP1 HP1BP3 DDX10 SLC25A3 MOGS AFG3L2 SHPRH TJP2 PLEC EEFSEC H1-10 FLNA NAT8B SLC25A5 POLRMT DYRK1A NR3C1 DIS3 EGFR SLC25A1 LPA H1-5 CTNNB1 RPL5 HERC5 | 1.30e-04 | 1215 | 207 | 27 | int:FBXW7 |
| Interaction | XIRP2 interactions | 1.30e-04 | 48 | 207 | 5 | int:XIRP2 | |
| Interaction | MECP2 interactions | SMC1A SRP72 PTBP1 DDX6 HP1BP3 ZNF512B SLC25A3 PTPN13 MOGS DDX18 ZNF483 MIOS PLEC ELOA FLNC RANGAP1 PDCD6IP SLC25A5 CHD7 EDIL3 SETD2 ZNF532 SLC25A1 GYS1 MRPS11 MRPL46 AGRN RPL5 | 1.38e-04 | 1287 | 207 | 28 | int:MECP2 |
| Interaction | ATG16L1 interactions | SMC1A SRPRA CCDC168 PTBP1 TTK SPICE1 SLC25A3 PASK PTPN13 MOGS AFG3L2 CCSER2 PLEC PLXNA2 EEFSEC FLNA NR3C1 DIS3 NOSIP EGFR ABCE1 SLC25A1 H1-5 CRYBG3 PATJ RPL5 | 1.55e-04 | 1161 | 207 | 26 | int:ATG16L1 |
| Interaction | SNCA interactions | SRPRA PTBP1 DDX6 HP1BP3 DDX18 FLNA FLNB RANGAP1 DYRK1A DIS3 GRK1 NOSIP EGFR SLC25A1 H1-1 CTNNB1 PATJ RPL5 HERC5 | 1.56e-04 | 716 | 207 | 19 | int:SNCA |
| Interaction | USP36 interactions | MYO6 SRP72 PTBP1 HP1BP3 DDX10 DDX18 SHPRH H1-10 FLNA ELOA RANGAP1 POLRMT CTNNB1 RPL5 DCAF4 HERC5 SOD2 | 1.59e-04 | 599 | 207 | 17 | int:USP36 |
| Interaction | COPS5 interactions | MLEC MYO6 RPS6KA3 SPART SRPRA PTBP1 ABCA10 DDX6 SLC25A3 MYOZ1 DDX18 FNIP1 SLC25A5 UBA2 SYT2 FIGN ACTR1A EGFR GYS1 ARFGAP1 MRPS11 SENP6 CTNNB1 RPL5 DCAF4 | 1.71e-04 | 1102 | 207 | 25 | int:COPS5 |
| Interaction | RPL10A interactions | CMTR1 SRP72 SRPRA DDX6 DDX10 DDX18 RANGAP1 SLC25A5 DYRK1A EGFR H1-5 H1-1 CTNNB1 RPL5 HERC5 | 1.74e-04 | 490 | 207 | 15 | int:RPL10A |
| Interaction | WDR76 interactions | IMPDH1 SMC1A MCCC2 PTBP1 SLC25A3 PLEC FLNA FLNB RANGAP1 SLC25A5 CHD8 CHD7 AGRN | 1.75e-04 | 383 | 207 | 13 | int:WDR76 |
| Interaction | NR3C1 interactions | MYH2 MLEC MYO6 SMC1A MIB1 FNIP1 TAF2 HYOU1 PDCD6IP CHD7 NR3C1 MORC4 SAR1A NOSIP WDR19 EGFR ABCE1 DDHD1 GYS1 ANKRD17 CTNNB1 NOMO3 DNAH11 | 1.78e-04 | 974 | 207 | 23 | int:NR3C1 |
| Interaction | RPS16 interactions | IMPDH1 CMTR1 MLEC SRP72 SRPRA DDX6 HP1BP3 DDX10 H1-10 KAT6A EGFR ABCE1 H1-3 H1-5 ANKRD17 H1-1 CTNNB1 RPL5 NOMO3 | 1.80e-04 | 724 | 207 | 19 | int:RPS16 |
| Interaction | ACE2 interactions | MYO6 SMC1A SLC6A19 SRP72 PTBP1 HP1BP3 SLC25A3 DDX18 CCSER2 PLEC H1-10 FLNA FLNB HYOU1 PDCD6IP SLC25A5 UBA2 DIS3 EGFR SLC25A1 H1-0 H1-5 PARD3 AGRN RPL5 | 1.81e-04 | 1106 | 207 | 25 | int:ACE2 |
| Interaction | RPL5 interactions | CMTR1 SRP72 SRPRA DDX6 HP1BP3 DDX18 TAF2 H1-10 SLC25A5 KAT6A EGFR ABCE1 H1-0 ANKRD17 RPL5 DCAF4 NOMO3 | 1.83e-04 | 606 | 207 | 17 | int:RPL5 |
| GeneFamily | Myosin heavy chains | 3.28e-06 | 15 | 130 | 4 | 1098 | |
| GeneFamily | Beta-gamma crystallin domain containing | 1.53e-04 | 3 | 130 | 2 | 1360 | |
| GeneFamily | Dyneins, axonemal | 2.29e-04 | 17 | 130 | 3 | 536 | |
| GeneFamily | Zinc fingers CW-type | 1.05e-03 | 7 | 130 | 2 | 96 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 1.05e-03 | 7 | 130 | 2 | 761 | |
| GeneFamily | Cohesin complex | 1.40e-03 | 8 | 130 | 2 | 1060 | |
| GeneFamily | Histones | 1.51e-03 | 116 | 130 | 5 | 864 | |
| GeneFamily | WD repeat domain containing | 2.89e-03 | 262 | 130 | 7 | 362 | |
| GeneFamily | DEAD-box helicases | 3.40e-03 | 42 | 130 | 3 | 499 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE | 6.22e-06 | 162 | 208 | 9 | M41204 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-08 | 184 | 209 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-08 | 184 | 209 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-08 | 184 | 209 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | MYO6 KANK1 PTPN13 PIP5K1B SFTPD EGFR CGNL1 PATJ PARD3 DNAH11 | 2.19e-08 | 188 | 209 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | 356C-Lymphocytic-ILC-ILC-2|ILC / Donor, Lineage, Cell class and subclass (all cells) | 1.29e-07 | 172 | 209 | 9 | 4977e1f4deae781750e27a8054deccd336cfb74a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.26e-07 | 133 | 209 | 8 | 5bf5e654653e2c340891f51e3f2a30441b7b6b2b | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 3.29e-07 | 192 | 209 | 9 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.59e-07 | 194 | 209 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.75e-07 | 195 | 209 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.26e-07 | 198 | 209 | 9 | cbb63b255bdc92a557c5db1f08f7766ed9346607 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.89e-06 | 176 | 209 | 8 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.23e-06 | 180 | 209 | 8 | 8e96f8646c002768b272359af485dc0ab57e0ccd | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.53e-06 | 183 | 209 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 184 | 209 | 8 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 184 | 209 | 8 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-06 | 184 | 209 | 8 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 3.47e-06 | 191 | 209 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 3.61e-06 | 192 | 209 | 8 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.89e-06 | 194 | 209 | 8 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 4.20e-06 | 196 | 209 | 8 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.36e-06 | 197 | 209 | 8 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | Caecum-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 4.70e-06 | 199 | 209 | 8 | 13173cc4dcc8e856680372b0a4ad4f36afa892c1 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.87e-06 | 200 | 209 | 8 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Transverse-T_cell-Activated_CD4_T|T_cell / Region, Cell class and subclass | 4.87e-06 | 200 | 209 | 8 | d89d3c16406d77cb08e1aa00d7df6887a692c337 | |
| ToppCell | Club-club-15|World / Class top | 1.93e-05 | 175 | 209 | 7 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-05 | 175 | 209 | 7 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.00e-05 | 176 | 209 | 7 | 5e46a09a36b9645b1b1fcb0b64bd0898561af3a9 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 177 | 209 | 7 | 14fb8d182775dfd0e49aa7e4e12543a85b3b8bd6 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 180 | 209 | 7 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 180 | 209 | 7 | dad458398683ff80a6e207bdc08e257d1bb757d6 | |
| ToppCell | P28-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-05 | 180 | 209 | 7 | 1e819c5c87704ec6535dfeaae56561895e239d07 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 180 | 209 | 7 | d9c9399df3e2d9f23dbbfffb6cbe8404bf01e2b7 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 182 | 209 | 7 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 182 | 209 | 7 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 182 | 209 | 7 | 812ff2a50a510b18d865e89465dba1754a08ef61 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.57e-05 | 183 | 209 | 7 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 183 | 209 | 7 | 24db9cc717e651586317c6a8e03a3401651273c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-Cd4_positive_Macrophages|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-05 | 183 | 209 | 7 | 92ef926e6c1de8477fa4f35d1dae85482d8009de | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 2.66e-05 | 184 | 209 | 7 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.66e-05 | 184 | 209 | 7 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 2.75e-05 | 185 | 209 | 7 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-05 | 186 | 209 | 7 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.05e-05 | 188 | 209 | 7 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 188 | 209 | 7 | 40ce7125fca6f6b6b5cc1637c87d43c29b08f4f1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 188 | 209 | 7 | ba7f7ce034c0f42742bf2461f68f8d343ee593a5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 189 | 209 | 7 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 189 | 209 | 7 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.16e-05 | 189 | 209 | 7 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.27e-05 | 190 | 209 | 7 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 191 | 209 | 7 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-05 | 191 | 209 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.38e-05 | 191 | 209 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | (1)_Osterolineage_cells-(10)_OLC-1|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.38e-05 | 191 | 209 | 7 | 78ad7c555409ce1391bce406bc0f3ef575329ece | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.38e-05 | 191 | 209 | 7 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 3.38e-05 | 191 | 209 | 7 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.49e-05 | 192 | 209 | 7 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.61e-05 | 193 | 209 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 3.61e-05 | 193 | 209 | 7 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | PCW_07-8.5|World / Celltypes from embryonic and fetal-stage human lung | 3.73e-05 | 194 | 209 | 7 | 5759c83308df017f1faae248e9b85388e25254f0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 194 | 209 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 194 | 209 | 7 | 12a2c60303607b8b5812405ad216d0612c56c64b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.73e-05 | 194 | 209 | 7 | 5eaaa81f4b2535f983c424aaef00077089526a5c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.73e-05 | 194 | 209 | 7 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.85e-05 | 195 | 209 | 7 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.85e-05 | 195 | 209 | 7 | e10b21e4dba4483efc4c82d6e395524246ca14a8 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 195 | 209 | 7 | 815ac5dacd382b11abb32011ed1c0635b0ddc779 | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD4+_Tcm|World / disease group, cell group and cell class (v2) | 3.85e-05 | 195 | 209 | 7 | a72bb5b1b15dd1ab70ced5622d94499caff8bb6b | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 3.85e-05 | 195 | 209 | 7 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.98e-05 | 196 | 209 | 7 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | 11.5-Distal-Mesenchymal-Airway_Smooth_Muscle|Distal / Age, Tissue, Lineage and Cell class | 3.98e-05 | 196 | 209 | 7 | 05530fe7a5681c2f39b95016cd22ef99d6ac0430 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 196 | 209 | 7 | 0e7ea6e66bfbb0006ee9651714fe48b0ee194290 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 196 | 209 | 7 | c936014125b2ed5f796221b74acb77b8f8359875 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.98e-05 | 196 | 209 | 7 | b10810c6a2ad3d3b968bfef46a68a38e0ce31331 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-05 | 196 | 209 | 7 | 208ddedd29e1b9ca89cbb9b527c2e193a44cada2 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.11e-05 | 197 | 209 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-05 | 197 | 209 | 7 | d14e1f2ba94240c61eac435db43508a224d606a8 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.11e-05 | 197 | 209 | 7 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.11e-05 | 197 | 209 | 7 | 51340570667914bffec741c72a8d09cc46abb8e8 | |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.11e-05 | 197 | 209 | 7 | 99fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 198 | 209 | 7 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | COVID-19-Heart-Mito_CM|Heart / Disease (COVID-19 only), tissue and cell type | 4.24e-05 | 198 | 209 | 7 | b6cd439863d17209b86dc50ae51282dc1725955d | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 198 | 209 | 7 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.24e-05 | 198 | 209 | 7 | daf367b699726286f0f0f7b4f3a6cf70c462fbeb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-05 | 199 | 209 | 7 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-05 | 199 | 209 | 7 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | Caecum-(1)_T_cell-(16)_Tfh|Caecum / shred on region, Cell_type, and subtype | 4.38e-05 | 199 | 209 | 7 | d07d77ae426dd1164d80d7031f14befa0369d3e5 | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.38e-05 | 199 | 209 | 7 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-05 | 199 | 209 | 7 | 534dcfe8b65ad92bb8d749d1c7036ad4807e09cd | |
| ToppCell | 11.5-Airway-Mesenchymal-Airway_Smooth_Muscle|Airway / Age, Tissue, Lineage and Cell class | 4.38e-05 | 199 | 209 | 7 | 1a8c77d241bd817a195e1532fd25f51358cb1ff1 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.38e-05 | 199 | 209 | 7 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Caecum-T_cell-Tfh|Caecum / Region, Cell class and subclass | 4.38e-05 | 199 | 209 | 7 | fb40f37d842f170ed101dfa3bffdb8f3b2c94f19 | |
| ToppCell | ILEUM-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.38e-05 | 199 | 209 | 7 | 615f20bf136dfef53b072667cf0e4df6a1017e05 | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.52e-05 | 200 | 209 | 7 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Macroglial-Glia_progenitor_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 4.52e-05 | 200 | 209 | 7 | 0b91c8da21ba488109f15c9b927c1dcaf8c6b0ae | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.52e-05 | 200 | 209 | 7 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.52e-05 | 200 | 209 | 7 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.64e-05 | 137 | 209 | 6 | 9324b55eac55e0cc1e8e450a4b5374d12e9587a3 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.64e-05 | 137 | 209 | 6 | 032f8409d0d179e254c8ff632afbda78852a9889 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.64e-05 | 137 | 209 | 6 | 265a4a50e48b13c8b3b0730f818235f71fbd6baa | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Nefh_(Cerebellum_basket_cells_1)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 6.90e-05 | 47 | 209 | 4 | 59811807a4b5baec55505bb4c38ac684b0a49c9a | |
| Drug | MgCl2 | MYH1 MYH2 MYH4 MYH7 MYO6 H1-9P SPTBN5 BPI ACTR1B ACTR1A FLAD1 ENTPD2 FSHR H1-0 H1-3 H1-5 H1-1 | 2.86e-08 | 354 | 207 | 17 | CID000024584 |
| Drug | NSC611747 | MYH1 MYH2 MYH4 MYH7 RPS6KA3 MBP H1-9P PASK FLNA ACTR1B ACTR1A H1-0 H1-3 H1-5 H1-1 CTNNB1 | 1.57e-07 | 352 | 207 | 16 | CID000002534 |
| Drug | SN-38 | 1.03e-06 | 184 | 207 | 11 | CID000104842 | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A | NCAM2 SRPRA DYRK4 ZNF512B PTPN13 RAB27A SAR1A DIS3 ABCG1 ARFGAP1 H1-3 | 1.82e-06 | 195 | 207 | 11 | 6234_DN |
| Drug | Minocycline hydrochloride [13614-98-7]; Down 200; 8uM; MCF7; HT_HG-U133A | MYO6 SMC1A GBP2 ZNF512B RANGAP1 GNB1L TBX19 SETD2 VPS13D MRPS11 SOD2 | 2.22e-06 | 199 | 207 | 11 | 5496_DN |
| Drug | Sedalipid | 7.31e-06 | 5 | 207 | 3 | CID000173846 | |
| Drug | AC1NFC6P | 8.78e-06 | 148 | 207 | 9 | CID000004587 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | GBP2 SRPRA PTBP1 HP1BP3 PLEC RAB27B VPS13D CSF1R MRPS11 PATJ | 9.52e-06 | 189 | 207 | 10 | 3262_DN |
| Drug | magnesium | SMC1A RPS6KA3 DDX10 PASK CLPB UGP2 PLEC RAB27B EEFSEC RANGAP1 REM1 SLC25A5 POLRMT CPS1 GABBR2 DNAH1 ACTR1B ACTR1A LIPT1 EGFR ABCE1 FLAD1 GYS1 DNAH17 ENTPD2 MRPS11 SMC1B SOD2 DNAH11 | 1.03e-05 | 1325 | 207 | 29 | CID000000888 |
| Drug | valproate | MYO6 NCAM1 H1-9P PCDHGA11 CPS1 GABBR2 SETD2 LPA H1-0 H1-3 H1-5 H1-1 CTNNB1 PCDHGA8 | 1.12e-05 | 381 | 207 | 14 | CID000003121 |
| Drug | 3-aminobenzamide | 1.34e-05 | 156 | 207 | 9 | CID000001645 | |
| Drug | glycogen | RPS6KA3 H1-9P PGM3 PASK MOGS CPT1C UGP2 APOB LIPE GYS1 H1-0 H1-3 H1-5 H1-1 CTNNB1 | 1.42e-05 | 443 | 207 | 15 | CID000439177 |
| Drug | carbachol | PLGLA MYH1 MYH2 MYH4 MYH7 MYO6 RPS6KA3 H1-9P TYRP1 ACTR1B ACTR1A EGFR LPA H1-0 H1-3 H1-5 H1-1 PATJ SOD2 | 1.84e-05 | 688 | 207 | 19 | CID000002551 |
| Drug | N-ethylmaleimide | MYH1 MYH2 MYH4 MYH7 MYO6 SLC25A3 SPTBN5 RAB27B SLC25A5 SYT2 FIGN ACTR1B ACTR1A EGFR LPA ENTPD2 | 1.92e-05 | 511 | 207 | 16 | CID000004362 |
| Drug | AC1LADJ6 | 2.56e-05 | 130 | 207 | 8 | CID000486032 | |
| Drug | AC1OCADI | 2.56e-05 | 130 | 207 | 8 | CID006914639 | |
| Drug | In-G | 2.66e-05 | 170 | 207 | 9 | CID000446054 | |
| Drug | S-(-)-Etomoxir | 3.63e-05 | 100 | 207 | 7 | CID000060765 | |
| Drug | syntide-2 | 4.60e-05 | 71 | 207 | 6 | CID005074902 | |
| Disease | myopathy (implicated_via_orthology) | 3.94e-08 | 48 | 204 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 3.26e-07 | 3 | 204 | 3 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 3.26e-07 | 3 | 204 | 3 | DOID:0111190 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 4.51e-07 | 10 | 204 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.05e-06 | 12 | 204 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.05e-06 | 12 | 204 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.41e-06 | 80 | 204 | 7 | DOID:12930 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.51e-06 | 13 | 204 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 2.85e-06 | 15 | 204 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | chylomicron measurement, triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 8.74e-05 | 34 | 204 | 4 | EFO_0008317, EFO_0008596, EFO_0020947 | |
| Disease | lipoprotein A measurement | 1.32e-04 | 112 | 204 | 6 | EFO_0006925 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.35e-04 | 71 | 204 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.84e-04 | 41 | 204 | 4 | DOID:10584 (is_implicated_in) | |
| Disease | congenital myasthenic syndrome (is_implicated_in) | 2.83e-04 | 4 | 204 | 2 | DOID:3635 (is_implicated_in) | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 2.91e-04 | 19 | 204 | 3 | C0751884 | |
| Disease | Cardiomyopathy, Dilated | 3.40e-04 | 48 | 204 | 4 | C0007193 | |
| Disease | alpha-tocopherol measurement | 3.40e-04 | 20 | 204 | 3 | EFO_0007898 | |
| Disease | Cardiomyopathy, Familial Idiopathic | 3.98e-04 | 50 | 204 | 4 | C1449563 | |
| Disease | Malignant Cystosarcoma Phyllodes | 4.69e-04 | 5 | 204 | 2 | C0600066 | |
| Disease | Phyllodes Tumor | 4.69e-04 | 5 | 204 | 2 | C0010701 | |
| Disease | chronic kidney disease, APOL1 risk genotype carrier status | 4.69e-04 | 5 | 204 | 2 | EFO_0003884, EFO_0009324 | |
| Disease | plasma plasminogen measurement | 4.69e-04 | 5 | 204 | 2 | EFO_0006309 | |
| Disease | Degenerative polyarthritis | 4.77e-04 | 93 | 204 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 4.77e-04 | 93 | 204 | 5 | C0086743 | |
| Disease | cancer (implicated_via_orthology) | 5.85e-04 | 268 | 204 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | Myasthenic Syndromes, Congenital | 5.92e-04 | 24 | 204 | 3 | C0751882 | |
| Disease | Coronary heart disease | 5.92e-04 | 24 | 204 | 3 | C0010068 | |
| Disease | ovarian cancer (is_implicated_in) | 6.15e-04 | 56 | 204 | 4 | DOID:2394 (is_implicated_in) | |
| Disease | primary biliary cholangitis (is_marker_for) | 6.69e-04 | 25 | 204 | 3 | DOID:12236 (is_marker_for) | |
| Disease | inclusion body myositis (is_implicated_in) | 7.01e-04 | 6 | 204 | 2 | DOID:3429 (is_implicated_in) | |
| Disease | angiostatin measurement | 7.01e-04 | 6 | 204 | 2 | EFO_0008024 | |
| Disease | Colorectal Neoplasms | 7.25e-04 | 277 | 204 | 8 | C0009404 | |
| Disease | concentration of chylomicrons and extremely large VLDL particles measurement | 7.50e-04 | 59 | 204 | 4 | EFO_0022260 | |
| Disease | total lipids in chylomicrons and extremely large VLDL measurement | 9.04e-04 | 62 | 204 | 4 | EFO_0022306 | |
| Disease | phospholipids in chylomicrons and extremely large VLDL measurement | 9.61e-04 | 63 | 204 | 4 | EFO_0022292 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 9.76e-04 | 7 | 204 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | lipoprotein A measurement, apolipoprotein A 1 measurement | 9.76e-04 | 7 | 204 | 2 | EFO_0004614, EFO_0006925 | |
| Disease | Ciliopathies | 1.02e-03 | 110 | 204 | 5 | C4277690 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.14e-03 | 66 | 204 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | Epileptic encephalopathy | 1.15e-03 | 30 | 204 | 3 | C0543888 | |
| Disease | Endotoxemia | 1.30e-03 | 8 | 204 | 2 | C0376618 | |
| Disease | Malignant neoplasm of breast | MYH1 RPS6KA3 PKDREJ DDX10 DDX18 FLNA FLNB GNB1L HELQ PCDH20 SETD2 LIPE CSF1R EGFR ZNF532 CTNNB1 SOD2 | 1.35e-03 | 1074 | 204 | 17 | C0006142 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 1.50e-03 | 71 | 204 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Major Depressive Disorder | 1.57e-03 | 243 | 204 | 7 | C1269683 | |
| Disease | Oxidative Phosphorylation Deficiencies | 1.66e-03 | 9 | 204 | 2 | C0949856 | |
| Disease | Mitochondrial Respiratory Chain Deficiencies | 1.66e-03 | 9 | 204 | 2 | C0949857 | |
| Disease | Electron Transport Chain Deficiencies, Mitochondrial | 1.66e-03 | 9 | 204 | 2 | C0949855 | |
| Disease | angina pectoris | 1.80e-03 | 125 | 204 | 5 | EFO_0003913 | |
| Disease | serine measurement | 1.81e-03 | 35 | 204 | 3 | EFO_0009774 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 1.81e-03 | 35 | 204 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | lung disease (biomarker_via_orthology) | 1.81e-03 | 35 | 204 | 3 | DOID:850 (biomarker_via_orthology) | |
| Disease | lung squamous cell carcinoma (is_marker_for) | 1.97e-03 | 36 | 204 | 3 | DOID:3907 (is_marker_for) | |
| Disease | renal cell carcinoma (is_marker_for) | 2.00e-03 | 128 | 204 | 5 | DOID:4450 (is_marker_for) | |
| Disease | Malignant Neoplasms | 2.00e-03 | 128 | 204 | 5 | C0006826 | |
| Disease | myelodysplastic syndrome | 2.06e-03 | 10 | 204 | 2 | EFO_0000198 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 2.13e-03 | 37 | 204 | 3 | EFO_0022252 | |
| Disease | Malignant neoplasm of brain | 2.30e-03 | 38 | 204 | 3 | C0153633 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.33e-03 | 80 | 204 | 4 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Brain Neoplasms | 2.48e-03 | 39 | 204 | 3 | C0006118 | |
| Disease | Hypercholesterolemia | 2.48e-03 | 39 | 204 | 3 | C0020443 | |
| Disease | gastrointestinal stromal tumor (is_implicated_in) | 2.51e-03 | 11 | 204 | 2 | DOID:9253 (is_implicated_in) | |
| Disease | lipoprotein-associated phospholipase A(2) measurement | 2.66e-03 | 40 | 204 | 3 | EFO_0004746 | |
| Disease | clinical treatment | 2.86e-03 | 41 | 204 | 3 | EFO_0007056 | |
| Disease | congestive heart failure (implicated_via_orthology) | 2.86e-03 | 41 | 204 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | Autism Spectrum Disorders | 2.90e-03 | 85 | 204 | 4 | C1510586 | |
| Disease | Papilloma | 3.00e-03 | 12 | 204 | 2 | C0030354 | |
| Disease | Papillomatosis | 3.00e-03 | 12 | 204 | 2 | C0205875 | |
| Disease | Papilloma, Squamous Cell | 3.00e-03 | 12 | 204 | 2 | C0205874 | |
| Disease | Leigh disease (implicated_via_orthology) | 3.00e-03 | 12 | 204 | 2 | DOID:3652 (implicated_via_orthology) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 3.07e-03 | 42 | 204 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | cholesteryl esters to total lipids in small LDL percentage | 3.07e-03 | 42 | 204 | 3 | EFO_0022255 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.28e-03 | 43 | 204 | 3 | EFO_0022290 | |
| Disease | Colorectal Carcinoma | ABCA10 FLNC GRID1 APOB ABCG1 EGFR ABCE1 PANK4 H1-5 CTNNB1 DSEL SOD2 | 3.72e-03 | 702 | 204 | 12 | C0009402 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.73e-03 | 45 | 204 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.73e-03 | 45 | 204 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Malignant neoplasm of prostate | KAT6A RFX6 CHD7 NR3C1 SETD2 EGFR SENP6 CTNNB1 PATJ PARD3 SOD2 | 3.91e-03 | 616 | 204 | 11 | C0376358 |
| Disease | Prostatic Neoplasms | KAT6A RFX6 CHD7 NR3C1 SETD2 EGFR SENP6 CTNNB1 PATJ PARD3 SOD2 | 3.91e-03 | 616 | 204 | 11 | C0033578 |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 3.97e-03 | 46 | 204 | 3 | EFO_0008317, EFO_0008596, EFO_0020943 | |
| Disease | Neurodevelopmental Disorders | 4.01e-03 | 93 | 204 | 4 | C1535926 | |
| Disease | Left ventricular noncompaction | 4.10e-03 | 14 | 204 | 2 | C1960469 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 4.10e-03 | 14 | 204 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | triacylglycerol 48:4 measurement | 4.10e-03 | 14 | 204 | 2 | EFO_0010407 | |
| Disease | Seizures | 4.21e-03 | 218 | 204 | 6 | C0036572 | |
| Disease | carotid artery intima media thickness | 4.28e-03 | 450 | 204 | 9 | EFO_0007117 | |
| Disease | chylomicron measurement, triglyceride measurement, very low density lipoprotein cholesterol measurement | 4.49e-03 | 96 | 204 | 4 | EFO_0004530, EFO_0008317, EFO_0008596 | |
| Disease | response to statin, LDL cholesterol change measurement | 4.71e-03 | 15 | 204 | 2 | EFO_0007804, GO_0036273 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 4.71e-03 | 15 | 204 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 4.71e-03 | 15 | 204 | 2 | EFO_0022328 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 4.75e-03 | 49 | 204 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | hearing impairment | 4.83e-03 | 98 | 204 | 4 | C1384666 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 5.01e-03 | 99 | 204 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 5.03e-03 | 50 | 204 | 3 | EFO_0022303 | |
| Disease | hypertension (biomarker_via_orthology) | 5.11e-03 | 227 | 204 | 6 | DOID:10763 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YDGGSAKTILNNGKT | 51 | P07451 | |
| ILARAKNGTGKSGAY | 136 | P26196 | |
| LFTVNDVKVGGSKYG | 186 | Q8WV16 | |
| GLSVQLFNDGSKGKL | 231 | O95394 | |
| NYGLELVTGSAKNGT | 1071 | Q8NHU2 | |
| VAGTANGGKVTFTKV | 191 | Q9HCK8 | |
| GNLFNISGKSSLGEA | 126 | Q68DQ2 | |
| NGKTGKVEALQGIFF | 401 | Q8WWZ4 | |
| GYKTLLKGISGKFNS | 96 | P45844 | |
| LKGISGKFNSGELVA | 101 | P45844 | |
| GGLFSVGETTAKVLK | 286 | Q9Y4W6 | |
| LKQTKGVGASGSFRL | 81 | P07305 | |
| LVQTKGTGASGSFKL | 96 | Q02539 | |
| ANIVLSGGSTLFKGF | 296 | P42025 | |
| GQKTDGKGDFVSLAL | 1681 | O00468 | |
| KSDGIKGLYQGFNVS | 166 | P05141 | |
| KSIGNIYKGLVQTGA | 1926 | Q96DT5 | |
| FVVGNAGTGKSKILR | 2171 | Q96DT5 | |
| GVSQLASKVQGVGSK | 271 | Q8N6T3 | |
| ASDTFSGIGKKFGLL | 61 | Q15847 | |
| IDSLIGKGSFGQVVK | 161 | Q13627 | |
| AAGIGKLSTADGKAF | 181 | O75179 | |
| ILEKNFTFLSKGGGQ | 1221 | Q9P2D1 | |
| NVTGQGKKLFGSGNV | 1296 | Q8IXJ9 | |
| GKKLFGSGNVAATLQ | 1301 | Q8IXJ9 | |
| QITGKGASGTFQLKK | 316 | Q5SSJ5 | |
| KQGKLVTGFSNGSIS | 1056 | Q149M9 | |
| TQVAGGQLSFKGKSL | 16 | P46060 | |
| FCGKIKGLSGVSTKN | 451 | Q9Y5P3 | |
| KFLALGDSGVGKTSV | 11 | P51159 | |
| KLLALGDSGVGKTTF | 11 | O00194 | |
| GSQKDTTFTKIFVGG | 26 | Q9H0Z9 | |
| FTGFSVNGKVLSKGQ | 126 | P69849 | |
| KGLTRFSGSKLKNEG | 211 | Q8HWS3 | |
| FSGSKLKNEGGFTRK | 216 | Q8HWS3 | |
| KGSFVGNISKDLGLD | 41 | Q9Y5G5 | |
| EKGSFVGNISKDLGL | 41 | Q9Y5H2 | |
| GKAKKGSSFQTVSAL | 636 | P12883 | |
| TGFAGSGVKLQAEKS | 281 | Q9Y314 | |
| STLKFIGQYGNGLKS | 91 | Q86VD1 | |
| SVANKLGSFGKTLGS | 501 | Q6GQQ9 | |
| NTGVIKLFSKIGGSV | 376 | Q8N6Y1 | |
| YGNQESKLIILASGG | 306 | P35222 | |
| SQLGATFFKIAGSGL | 541 | Q5HY92 | |
| FTGFSVNGKVLSKGQ | 126 | Q5JPE7 | |
| LTLFGYGKTELLGKN | 366 | Q96RG2 | |
| GIKATSVYNGKGGLI | 36 | Q7L273 | |
| KGIFNGFSVTLKEDG | 101 | Q00325 | |
| GTGLQGQAVFKTKLT | 476 | Q8WVC0 | |
| KNVLLTGATGFLGKV | 11 | Q8WVX9 | |
| KGGNSSVKLEAGLAN | 186 | P43026 | |
| FDSQKARGISGSAGK | 216 | Q9BYB4 | |
| GSLIDTKGNKIAGFD | 1641 | Q86YW9 | |
| GNNGVLFSESAKKGT | 371 | Q9HCC0 | |
| DGLTFQGLGALKSLK | 231 | Q6UXM1 | |
| GKLSVQGEVSTFTGK | 176 | Q14165 | |
| TLLQVKGTGANGSFK | 101 | Q92522 | |
| QGSFGKVFLVKKISG | 76 | P51812 | |
| LDGQFKISGTASKIG | 156 | Q9Y234 | |
| KQVIDLGSGKGYLSS | 176 | Q8N6Q8 | |
| GGVIFQKKAADTAVG | 421 | Q9Y5L3 | |
| VLGKLESGSIFKGQQ | 446 | Q8IYD1 | |
| GLSKAFVGQKSSFLV | 2521 | O75369 | |
| KGSLFGGSVKLALAS | 101 | Q8WUM4 | |
| NGYSVVFVGTKSGKL | 441 | O75051 | |
| GANTILGRKSGVATK | 391 | Q9HCI6 | |
| QKSDGKIAASRSGGF | 26 | Q7Z5P9 | |
| SFVKGTIQSREGGKV | 46 | Q9UKX2 | |
| SSAIKGAIQLGIGYT | 26 | O14986 | |
| LTGGADKGKFVALEN | 171 | Q8TAT6 | |
| GAGKAKLDVQFAGTA | 896 | Q14315 | |
| FTGFSVNGKVLSKGQ | 126 | Q15155 | |
| KVNGSASGKAGDILS | 6 | Q14678 | |
| NKLAGKKNGFSLGST | 56 | P32456 | |
| NKLAGKNKGFSLGST | 56 | Q9H0R5 | |
| KGQTGTNGGNVKLYT | 171 | P04150 | |
| GKKKGSSFQTVSALF | 641 | P12882 | |
| KFGKILGEGSFSTVV | 56 | Q6A1A2 | |
| AAAKTGSGKTLAFLI | 221 | Q9NVP1 | |
| SAKEGGAFNKGIAVL | 261 | Q8NGE1 | |
| ASLFSVTKKQLGAGS | 31 | Q15195 | |
| SASLEGKGQLKFTSG | 176 | Q53HC9 | |
| TQNGKVKLGDFGSAR | 136 | P51956 | |
| FSEGDKVKIAQGVSG | 431 | P20839 | |
| GLGTQGAEKKSAASI | 741 | Q86YT6 | |
| VGAKGQLKFISGHTS | 221 | Q13724 | |
| ETKVIQATGGGAYKF | 116 | Q9NVE7 | |
| SGSFVGNLAKDLGLK | 41 | Q9Y5F2 | |
| KVFSFGSGKDGQLGN | 316 | Q9UII4 | |
| KGQKDVSALFGGSAA | 126 | Q92794 | |
| KKGRGVIFGQTSSTF | 956 | A6NKT7 | |
| DKNGIKGGLKSVSLF | 106 | Q9H7U1 | |
| DKSFTLIVFSNGKLG | 451 | Q8TCG5 | |
| FSKKLSAISLGQGQG | 3696 | Q9P2D7 | |
| VLETIGKGSFGQVAK | 106 | Q9NR20 | |
| TKVTGIITQGAKDFG | 386 | O43854 | |
| FGTSGQKTKIISNRG | 481 | P00533 | |
| TNGIGKSTALKILAG | 111 | P61221 | |
| NGKVIGTLKNSLFFS | 3026 | P04114 | |
| GLSKYLESNGIKVSG | 116 | P31327 | |
| GNLITGLAAGAKTYK | 296 | P31327 | |
| KTLGAGAFGKVVEAT | 586 | P07333 | |
| FGSQNLTTVKLKGVG | 511 | Q9Y4L1 | |
| LVQTKGTGASGSFKL | 96 | P16401 | |
| TATFTIQKKAGGAKA | 3051 | Q9H799 | |
| IVGNAGSGKSQVLKS | 2126 | Q9UFH2 | |
| KSKQGLDSFDTGKGA | 366 | Q14241 | |
| GKQSVGRTFAKLQGA | 436 | Q0VF96 | |
| AAGKGKLDVQFSGLT | 901 | P21333 | |
| SVSKLGSDAQVKVFG | 71 | Q8TF40 | |
| GLKFSISNANIKISG | 106 | P17213 | |
| NIKQLTGGTYTGKAL | 511 | A8TX70 | |
| IVGLKGNSGQSVYSA | 136 | Q8N4T8 | |
| SILYLGGNTKTGKAI | 106 | Q96P44 | |
| GGNTKTGKAIQFALD | 111 | Q96P44 | |
| SNIVLSGGSTLFKGF | 296 | P61163 | |
| TQGTFGTGLLKEAQL | 1946 | P08519 | |
| QGTLSKIFKLGGRDS | 281 | P02686 | |
| GNFTESTDGGKAILK | 841 | O75899 | |
| GNVISALGDDKKGSF | 271 | Q2VIQ3 | |
| IGNSISSKGYGIALQ | 761 | Q9ULK0 | |
| LGTKIYTEQQGTKGS | 261 | A0A1B0GTZ2 | |
| GSSGIGKTELAKQTA | 381 | Q9H078 | |
| NIGKASILGAASIGK | 741 | Q8NEL9 | |
| GAAKTGSGKTLAFLV | 111 | Q13206 | |
| YSFKKGVGSGLEDNT | 6 | Q8NDH2 | |
| EKNFGSKGSSIDVLG | 1326 | Q9Y4K1 | |
| ILGVSESFIGKKASG | 906 | Q8TDG4 | |
| ESFIGKKASGQAIGK | 911 | Q8TDG4 | |
| LKGLVDKGSAGSFTL | 161 | P60008 | |
| DKGSAGSFTLGKKQA | 166 | P60008 | |
| TKLRVIQKGAFSGFG | 56 | P23945 | |
| ELLDGQSKTKGYAGT | 341 | Q15835 | |
| GGIYTVLQTKAKVTG | 41 | P13807 | |
| QTKGTGASGSFKLNK | 96 | P16402 | |
| ESGSSLGKKVAGALQ | 371 | Q8NFF5 | |
| SASSIQKTGGVAGKF | 1401 | D6RIA3 | |
| TGHVGFIFKNGKITS | 206 | O00560 | |
| SKVKQIGGGIQSITY | 1086 | O00411 | |
| TFVSFKSGKLGGRAV | 431 | Q8IZU8 | |
| TLTNVGGLGTTFKFL | 641 | Q9C0B2 | |
| SGSEQKFLIGLGKSQ | 596 | Q8N1G2 | |
| VQGAKSKQGSLTELG | 191 | Q05469 | |
| KGGVGKSTTAVNLAL | 76 | Q8TB37 | |
| KGSLGFTVTKGNQRI | 1796 | Q12923 | |
| NIQLKKGTEGLGFSI | 461 | Q8TEW0 | |
| VGKTSLASLFAGKQE | 91 | O75628 | |
| SLKNGSATGGGNKVY | 81 | Q13416 | |
| AKGAVQGGLDTSKAV | 136 | Q96Q06 | |
| AKGAVQGGLDTTKSV | 466 | Q96Q06 | |
| VAKGAVQGGLDTTKS | 531 | Q96Q06 | |
| VAKGAVQGGLDTTKS | 861 | Q96Q06 | |
| GKNEAIGKIFVGSNA | 366 | Q8N9I0 | |
| GGDKALKFFSITGQT | 146 | O75031 | |
| KYTGLGQKASLGGLQ | 4886 | O75445 | |
| ALLLTGDFSQAGNKG | 236 | Q9H2W6 | |
| GLTLKGATNGIVFLF | 241 | Q695T7 | |
| KAVFSILNTGGFLGT | 96 | Q96AM1 | |
| LIIYKNGTSKKGGQA | 491 | Q9Y6U3 | |
| TLTAAGIINLTGGKY | 311 | Q96NR3 | |
| EQKGSVGATFKLGDS | 1396 | Q9HCM1 | |
| SGFLKSISNVSGKDI | 501 | Q6P1X5 | |
| GSLKKTTGGFSFQVD | 976 | Q9NTG1 | |
| LKFSLQGLKIYSGEG | 66 | Q6ZV89 | |
| RLGKDALVFTKNGGT | 131 | Q8TE76 | |
| VKQIKGHGFSGTFTL | 496 | Q149N8 | |
| ARTTTGNKVFGALKG | 151 | P46777 | |
| GKLVFLGLDNAGKTT | 26 | Q9NR31 | |
| TAGYLGQVTTIKKGV | 141 | Q9UBT2 | |
| GKKKGSSFQTVSALF | 641 | Q9Y623 | |
| SKVGSFLAVGTVKGN | 106 | Q8NEZ3 | |
| LENSAGATYIRKKGG | 521 | O76094 | |
| ASLFSVTKKQLGAGS | 31 | P00747 | |
| KLQQGIKSGTYLQGT | 236 | Q9Y2L1 | |
| LASQKQAAKGGESLG | 1746 | Q9NRC6 | |
| VKGLQSSQGLTGFTL | 356 | Q8N0Z3 | |
| GGGLEAKAKALFNTL | 101 | Q9P291 | |
| GEISILNIKGSKAGN | 541 | P29973 | |
| GKGLGEISAASEFKT | 591 | P13591 | |
| KKGTGIAAQTAGIAA | 121 | P82912 | |
| LKALGGENSSKTGLS | 176 | Q9HCE3 | |
| SGDVTFGKNVSLKGT | 461 | Q16851 | |
| GIIDSAFGQSGKFKI | 516 | P57772 | |
| KQATGGAAKVSQFLV | 481 | Q8N0X7 | |
| VKKTFLGVGQESFGE | 196 | P17643 | |
| KGVNNFGGFKTKGIN | 791 | Q5W0Q7 | |
| LQKDSKRGFGIAVSG | 36 | Q9UDY2 | |
| GNKGSLVYAGIKSIV | 446 | Q9NXC5 | |
| GKSFKLSITKQDDGG | 606 | O15394 | |
| VKLADFGLSTFQGGS | 156 | Q9Y572 | |
| NGQSVGEKIFKTAGF | 256 | P35247 | |
| FLKSGVISGGSSDLK | 646 | Q8NDV3 | |
| KRNGSGVFISDIVKG | 1551 | Q8NI35 | |
| GGYSISFLKQLIAGK | 36 | Q96S82 | |
| GLKGTYQGLTATVLK | 176 | P53007 | |
| FQKSGVISGGASDLK | 646 | Q14683 | |
| SSGSVFGKGVKFALK | 2561 | Q6N022 | |
| KANLKGISGQDGFYV | 326 | A8MV23 | |
| GGQKSQNTGLTTKKF | 261 | Q9GZR1 | |
| VNGVGKSTNLAKISF | 426 | P08240 | |
| FKEKLTAASVGVQGS | 131 | P04179 | |
| SKGIYQSLEGAVQAG | 476 | Q15149 | |
| GSKKKSSQSEGIFLG | 306 | Q9BYW2 | |
| AVKGLGITIKNFFQG | 241 | Q0D2K0 | |
| SISGTFGLKGLVKAE | 436 | Q96KM6 | |
| SILKQIGSGGSSKVF | 526 | P33981 | |
| IKNSVGVNGDGKSFL | 151 | Q6PF04 | |
| RNTTLGFGLKGQSEK | 236 | O14771 | |
| GFGLKGQSEKSLLQE | 241 | O14771 | |
| AQNKTLGSGSRGKKF | 286 | Q8TF39 | |
| KGVSSGKGYILRNSV | 301 | Q6PF06 | |
| SFSKVKLTNKLNGGG | 141 | O60806 | |
| GKLVFLGLDNAGKTT | 26 | Q9Y6B6 | |
| QSSAKKESFGGQGTK | 286 | A4D1P6 | |
| KVLFSSNGGVVKGFK | 471 | P26599 | |
| GKGQLGEVKRFTSTS | 186 | Q6ZQQ6 | |
| KGKVHTSGFGYQSEL | 651 | Q5THJ4 | |
| GESGAGKTENTKFVL | 151 | Q9UM54 | |
| GLYQSLGFKKTGQSF | 186 | Q9UHF3 | |
| GVFVKNKYGSETGQV | 1406 | Q5VTT5 | |
| GQESSGLNLGKKISV | 26 | Q9NP98 |